Document:

Exhibit

SEPARATION AND RELEASE AGREEMENT
This Separation and Release Agreement (this “Agreement”) is entered by and between Matthew Plunkett (“Executive”) and CTI BioPharma Corp., a Washington corporation (the “Company”), on this 22nd day of August, 2017 (the “Effective Date”).
WHEREAS, Executive was employed by, and was an officer of, the Company, and Executive resigned from such positions with the Company as set forth below; and
WHEREAS, the parties desire to enter into this Agreement on the terms and conditions set forth below.
NOW, THEREFORE, in consideration of the covenants undertaken and the releases contained in this Agreement, Executive and the Company agree as follows:
1.Resignation.  Executive irrevocably resigned as an officer (including, without limitation, as Executive Vice President, Chief Business Officer of the Company), employee, manager and in each and every other capacity with the Company and each of its Affiliates (as such term is defined below), effective on August 22, 2017 (the “Separation Date”).  The Company confirms that such resignations were accepted.  Executive agrees that, after the Separation Date, he shall hold no such position.  Executive agrees that he has been paid all compensation and benefits due from the Company and each of its Affiliates (including, but not limited to, accrued vacation, salary, bonus, incentive, and other wages), and that all payments due to Executive from the Company or any of its Affiliates after the Effective Date shall be determined under this Agreement and the Consulting Agreement (as such term is defined below).  Without limiting the generality of the foregoing, Executive expressly acknowledges and agrees that he is not entitled to any payments or benefits under the Severance Agreement between Executive and the Company, dated January 6, 2015 (the “Severance Agreement”) and that such Severance Agreement is hereby terminated.  Executive agrees that within thirty (30) days after the Separation Date, he will submit all reimbursable business expenses to the Company and the Company agrees that it will reimburse such expenses in accordance with (and subject to) its expense reimbursement policy.  As used in this Agreement: (i) the term “Affiliate” means a person that directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company; (ii) the term “control,” including the correlative terms “controlling,” “controlled by” and “under common control with,” means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities or any partnership or other ownership interest, by contract or otherwise) of a person; and (iii) the term “person” shall be construed broadly and includes, without limitation, an individual, a partnership, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof.  All of Executive’s accrued but unused PTO as of the Separation Date will be paid to him on (or promptly following) the Separation Date.

1

2.    Consulting Agreement and Proprietary Information Agreement.  Concurrently with entering into this Agreement, Executive and the Company are entering into (a) the Consulting Agreement attached hereto as Exhibit A (the “Consulting Agreement”) and (b) the Proprietary Information and Inventions Assignment Agreement attached hereto as Exhibit B (the “Proprietary Information Agreement”).
3.    Executive’s Representation; Nondisparagement.  Executive has represented and hereby represents that in his actions undertaken as a Company officer and employee, he acted in good faith and in a manner that he reasonably believed to be in, or not opposed to, the best interests of the Company, and that Executive had a reasonable belief at all times that his conduct was lawful.  Executive acknowledges, understands, and agrees that the Company has relied and is relying on Executive’s representations and that these representations are and have been material to the Company in determining whether to enter into this Agreement and the Consulting Agreement.  Executive agrees not to defame or disparage the Company and will not make any statement of any kind which is calculated to, or which reasonably foreseeably will, damage the business or reputation of the Company.  The Company agrees that it will instruct the members of its management, Board of Directors and executive teams not to defame or disparage the Executive, or make any statement of any kind which is calculated to, or which reasonably foreseeably will, damage Executive’s personal or business reputation.  Notwithstanding the foregoing, nothing in this Agreement shall prohibit Executive or any of the Company’s officers or directors from providing truthful testimony in response to any court or arbitral order, subpoena, or government investigation, or from providing truthful information to any governmental, regulatory or administrative agency, or to the extent required by law.
4.    Severance.  Provided that Executive signs this Agreement and does not revoke it, and signs each of the Consulting Agreement and the Proprietary Information Agreement, the Company shall:
		
	(a)
	pay Executive an amount equal to Two Hundred Sixty-Five Thousand Dollars ($265,000), such amount to be paid in a lump sum on the Company’s first payroll date following January 1, 2018 (and in all cases not later than January 15, 2018), subject to tax withholding and other authorized deductions, in recognition of Executive’s performance during 2017; and

		
	(b)
	pay or reimburse the Executive for his premiums charged to continue medical coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), at the same or reasonably equivalent medical coverage under the group medical program available to the Company’s employees generally for Executive (and, if applicable, Executive’s spouse and eligible dependents) as in effect immediately prior to the Separation Date, to the extent that Executive elects such continued coverage; provided that the Company’s obligation to make any payment or reimbursement pursuant to this Section 4(b) shall commence with continuation coverage for September 2017 and shall cease with continuation coverage for February 2018 (or, if earlier, shall cease upon the first to occur of Executive’s death, the date Executive becomes eligible for coverage under the 

2

health plan of a future employer, or the date the Company ceases to offer group medical coverage to its active executive employees or the Company is otherwise under no obligation to offer COBRA continuation coverage to Executive).  To the extent Executive elects COBRA coverage, he shall notify the Company in writing of such election prior to such coverage taking effect and complete any other continuation coverage enrollment procedures the Company may then have in place.  The Company’s obligation to pay or reimburse for premiums pursuant to this Section 4(b) does not apply to any coverage that the Company (or one of its affiliates) is not required to offer Executive pursuant to COBRA.
The Company’s obligations pursuant to clause (b) above are subject to the Company’s ability to comply with applicable law and provide such benefit without resulting in adverse tax consequences.
Executive agrees that the Company may reduce any amount otherwise payable pursuant to clause (a) above by the amount of any required tax withholding or other authorized deduction otherwise required with respect to the payments and benefits contemplated by clause (b) above as well as any other required tax withholding amounts on other payments or reimbursements made by the Company for Executive’s benefit and that, if the amount otherwise payable pursuant to clause (a) above is not sufficient to satisfy all applicable tax withholding and other authorized deductions (for clarity, also taking into account the tax withholding and other authorized deductions with respect to the amount contemplated by clause (a)), Executive shall promptly make arrangements satisfactory to the Company to pay for such tax withholding and other authorized deductions.
5.    Equity Awards.  Prior to the Separation Date, the Company granted Executive the following stock options that remain outstanding on the Separation Date (together, the “Options”):
		
	(a)
	a stock option granted in December 2013 to purchase up to 29,998 shares of Company common stock at a per share exercise price of $17.70, such option being vested with respect to 100% of the shares as of the Separation Date;

		
	(b)
	a stock option granted in December 2015 to purchase up to 140,000 shares of Company common stock at a per share exercise price of $12.40 (the “December 2015 Option”), such option being vested with respect to 52,500 shares as of the Separation Date and unvested with respect to the remaining 87,500 shares as of the Separation Date; and

		
	(c)
	a stock option granted in March 2017 to purchase up to 60,000 shares of Company common stock at a per share exercise price of $4.33 (the “March 2017 Option”), such option being unvested with respect to 100% of the shares as of the Separation Date.

As a result of this Agreement, the March 2017 Option, to the extent then outstanding and unvested, shall be fully vested and exercisable as of the Separation Date, and each of the Options 

3

that is outstanding and vested on the Separation Date (after giving effect to such accelerated vesting) shall remain exercisable through the first to occur of (i) the date that is eighteen (18) months after the Separation Date and (ii) the expiration date of the Option as provided in the applicable option agreement; provided, however, that each such Option shall remain subject to earlier termination in connection with a change in control of the Company or a similar corporate transaction in accordance with the provisions of the equity incentive plan and/or option agreement applicable to such Option.  The December 2015 Option, to the extent then outstanding and unvested, shall terminate on the Separation Date, and Executive shall not be entitled to any further vesting with respect thereto for any services he may perform for the Company or its subsidiaries after the Separation Date.  
Executive has no rights under or with respect to any other incentive, equity or equity-based award of the Company or any of its Affiliates.  Executive has no right to receive any new incentive, equity or equity-based award from the Company or any of its Affiliates.
References to the numbers of shares and exercise prices above in this Section 5 are presented having been adjusted for stock splits, reverse stock splits, and stock dividends through the Separation Date and remain subject to adjustment in accordance with the terms and conditions of the applicable award.
6.    Release of Claims.  Executive, on his own behalf and on behalf of his descendants, dependents, heirs, executors, administrators, assigns and successors, and each of them, hereby fully and forever releases the Company, its divisions, subsidiaries, parents, or affiliated corporations, past and present, and each of them, as well as its and their assignees, successors, directors, officers, stockholders, partners, representatives, attorneys, agents or employees, past or present, or any of them (individually and collectively, “Releasees”), from, and agrees not to sue concerning, or in any manner institute, prosecute or pursue, or cause to be instituted, prosecuted, or pursued, any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any acts or omissions that have occurred up until and including the date and time that Executive signs the Agreement (collectively, “Claims”), including, without limitation, (a) any and all Claims relating to or arising from Executive’s employment relationship with the Company and the termination of that relationship; (b) any and all Claims for violation of any federal, state or municipal law, constitution, regulation, ordinance or common law, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Americans with Disabilities Act of 1990; the Fair Labor Standards Act; the Employee Retirement Income Security Act of 1974; and the federal Family Medical Leave Act; and all amendments to each such law; (c) any and all Claims for any wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied (including but not limited to Claims arising out of the Severance Agreement); breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; personal injury; invasion of privacy; false imprisonment; and conversion; 

4

(d) any and all Claims for wages, benefits, severance, vacation, bonuses, commissions, equity, expense reimbursements, or other compensation or benefits; and (e) any and all Claims for attorneys' fees, costs and/or penalties; provided, however, that the foregoing release does not apply to any obligation of the Company to Executive pursuant to any of the following: (1) this Agreement or the Consulting Agreement; (2) any right to indemnification that Executive may have pursuant to the Company’s bylaws, its corporate charter or under any written indemnification agreement with the Company (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys’ fees to the extent otherwise provided) that Executive may in the future incur with respect to his service as an employee or officer of the Company or any of its subsidiaries or affiliates; (3) with respect to any rights that Executive may have to insurance coverage for such losses, damages or expenses under any Company (or subsidiary or affiliate) directors and officers liability insurance policy; (4) any rights to continued medical and dental coverage that Executive may have under COBRA; and (5) any rights to exercise the vested Options in accordance with the terms and conditions applicable to the Options and as modified by this Agreement.  In addition, this release does not cover any Claim that cannot be so released as a matter of applicable law.  Notwithstanding anything to the contrary herein, nothing in this Agreement prohibits Executive from filing a charge with or participating in an investigation conducted by any state or federal government agencies.  However, Executive does waive, to the maximum extent permitted by law, the right to receive any monetary or other recovery, should any agency or any other person pursue any claims on Executive’s behalf arising out of any claim released pursuant to this Agreement.  For clarity, and as required by law, such waiver does not prevent Executive from accepting a whistleblower award from the Securities and Exchange Commission pursuant to Section 21F of the Securities Exchange Act of 1934, as amended.  Executive acknowledges and agrees that he has received any and all leave and other benefits that he has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.
7.    Waiver of Unknown Claims.  This Agreement is intended to be effective as a general release of and bar to each and every Claim hereinabove specified.  Executive acknowledges that he later may discover claims, demands, causes of action or facts in addition to or different from those which Executive now knows or believes to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected its terms.  Nevertheless, Executive hereby waives, as to the Claims, any claims, demands, and causes of action that might arise as a result of such different or additional claims, demands, causes of action or facts.  Without limiting the generality of the foregoing, Executive hereby expressly waives any rights and benefits conferred by Section 1542 of the California Civil Code and any similar provision of any other applicable state law as to the Claims.  Section 1542 of the California Civil Code provides:
“A GENERAL RELEASE DOES NOT EXTEND TO A CLAIM WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”

5

8.    ADEA Waiver.  Executive expressly acknowledges and agrees that by entering into this Agreement, he is waiving any and all rights or claims that he may have arising under the Age Discrimination in Employment Act of 1967, as amended (the “ADEA”), and that this waiver and release is knowing and voluntary.  Executive and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date Executive signs this Agreement.  Executive further expressly acknowledges and agrees that:
(a)    In return for this Agreement, he will receive consideration beyond that which he was already entitled to receive before executing this Agreement; 
(b)    He is hereby advised in writing by this Agreement to consult with an attorney before signing this Agreement;
(c)    He was given a copy of this Agreement on August 8, 2017, and informed that he had twenty-one (21) days within which to consider this Agreement and that if he wished to execute this Agreement prior to the expiration of such 21-day period he will have done so voluntarily and with full knowledge that he is waiving his right to have twenty-one (21) days to consider this Agreement; and that such twenty-one (21) day period to consider this Agreement would not and will not be re-started or extended based on any changes, whether material or immaterial, that are or were made to this Agreement in such twenty-one (21) day period after he received it; 
(d)    He was informed that he had seven (7) days following the date of execution of this Agreement in which to revoke this Agreement, and this Agreement will become null and void if Executive elects revocation during that time.  Any revocation must be in writing and must be received by the Company during the seven-day revocation period.  In the event that Executive exercises this revocation right, then neither the Company nor Executive will have any obligation under this Agreement or under the Consulting Agreement.  Any notice of revocation should be sent by Executive in writing in accordance with the notice provisions set forth below in this Agreement so that it is received within the seven-day period following execution of this Agreement by Executive.
(e)    Nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law.
9.    No Transferred Claims.  Executive warrants and represents that he has not heretofore assigned or transferred to any person not a party to this Agreement any released matter or any part or portion thereof.
10.    Ongoing Obligations.  Executive shall, and Executive hereby agrees that he will, comply with his continuing obligations under the Proprietary Information Agreement that survive the termination of Executive’s employment with the Company.  Executive has no further rights under the Severance Agreement.

6

11.    Arbitration.  Any non-time barred, legally actionable controversy or claim arising out of or relating to this Agreement, the Consulting Agreement or any agreement evidencing an Option, the enforcement, arbitrability or interpretation of any such agreement, or because of an alleged breach, default, or misrepresentation in connection with any such agreement’s provisions, or any other  non-time barred, legally actionable controversy or claim arising out of or relating to Executive’s employment or association with the Company or termination of the same, including, without limiting the generality of the foregoing, any alleged violation of state or federal statute, common law or constitution, shall be submitted to individual, final and binding arbitration, to be held in King County, Washington, before a panel of three arbitrators selected from Judicial Arbitration and Mediation Services, Inc. (“JAMS”), in accordance with the then-current JAMS Arbitration Rules and Procedures for employment disputes, as modified by the terms and conditions in this Section (which may be found at www.jamsadr.com under the Rules/Clauses tab).  The parties will select the arbitrator by mutual agreement or, if the parties cannot agree, then by striking from a list of qualified arbitrators supplied by JAMS from their labor and employment law panel.  Final resolution of any dispute through arbitration may include any remedy or relief that is provided for through any applicable state or federal statutes, or common law.  Statutes of limitations shall be the same as would be applicable were the action to be brought in court.  The arbitrator selected pursuant to this Agreement may order such discovery as is necessary for a full and fair exploration of the issues and dispute, consistent with the expedited nature of arbitration.  At the conclusion of the arbitration, the arbitrator shall issue a written decision that sets forth the essential findings and conclusions upon which the arbitrator’s award or decision is based.  Any award or relief granted by the arbitrator under this Agreement shall be final and binding on the parties to this Agreement and may be enforced by any court of competent jurisdiction.  The Company will pay those arbitration costs that are unique to arbitration, including the arbitrator’s fee (recognizing that each side bears its own deposition, witness, expert and attorneys’ fees and other expenses to the same extent as if the matter were being heard in court).  If, however, any party prevails on a statutory claim, which affords the prevailing party attorneys’ fees and costs, then the arbitrator may award reasonable fees and costs to the prevailing party.  The arbitrator may not award attorneys’ fees to a party that would not otherwise be entitled to such an award under the applicable statute.  The arbitrator shall resolve any dispute as to the reasonableness of any fee or cost.   The parties acknowledge and agree that they are hereby waiving any rights to trial by jury or a court in any action or proceeding brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with this Agreement or Executive’s employment.
12.    Miscellaneous.
(a)    Successors.
•This Agreement is personal to Executive and shall not be assignable by Executive, but in the event of Executive’s death any payment and benefits due to Executive under this Agreement shall (to the extent not theretofore paid or provided) be paid or provided to the benefit of Executive’s heirs and estate 

7

(provided that in such circumstances the Company would have no further obligation pursuant to Section 4(b)).
•This Agreement shall inure to the benefit of and be binding upon the Company and its respective successors and assigns and any such successor or assignee shall be deemed substituted for the Company under the terms of this Agreement for all purposes.  As used herein, “successor” and “assignee” shall include any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires ownership of the Company or to which the Company assigns this Agreement by operation of law or otherwise.
(b)    Notices.  All notices, requests, demands and other communications called for by this Agreement or the Consulting Agreement will be in writing and will be deemed given (1) on the date of delivery if delivered personally, by facsimile or by electronic mail, (2) one (1) day after being sent by a well-established commercial overnight service, or (3) four (4) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties may later designate in writing:
If to the Company:
Chief Executive Officer
CTI BioPharma Corp.
3101 Western Avenue, Suite 600
Seattle, Washington  98121 

with a copy (which shall not constitute notice) to:
C. Brophy Christensen, Esq.
O’Melveny & Myers LLP
Two Embarcadero Center,  28th Floor
San Francisco, CA  94111-3823

If to Executive:
at the last residential address reflected on the Company’s records.
(c)    Waiver.  Neither the failure nor any delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed as a waiver of such right, remedy, power or privilege with 

8

respect to any other occurrence.  No waiver shall be binding unless in writing and signed by the party asserted to have granted such waiver.
(d)    Modification.  This Agreement may not be amended, modified or changed (in whole or in part), except by a formal, definitive written agreement expressly referring to this Agreement, which agreement is executed by both of the parties hereto.
(e)    Complete Agreement.  This Agreement, together with the Proprietary Information Agreement and the Consulting Agreement, constitutes and contains the entire agreement and final understanding concerning Executive’s relationship with the Company and its Affiliates and the other subject matters addressed herein and supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether written or oral, concerning the subject matters hereof.  Any representation, promise or agreement not specifically included in this Agreement or in the Proprietary Information Agreement or the Consulting Agreement shall not be binding upon or enforceable against either party.  The Executive is not relying on any representation of the Company or any of the Releasees except as expressly set forth in this Agreement or in the Proprietary Information Agreement or the Consulting Agreement.  This Agreement, together with the Proprietary Information Agreement and the Consulting Agreement, constitutes an integrated agreement.  The written terms and conditions applicable to the Options, as modified by this Agreement, are outside of the scope of the foregoing integration provisions.
(f)    Severability.  In the event that any portion of this Agreement or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such portion to other persons or circumstances will be interpreted so as reasonable to effect the intent of the parties hereto.
(g)    Governing Law.  This Agreement shall be deemed to have been executed and delivered within the State of Washington, and, except for Section 11, which shall be governed by the Federal Arbitration Act (both substantively and procedurally), the rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of Washington without regard to principles of conflict of laws.  The parties agree that Executive’s job duties as the Company’s Executive Vice President, Chief Business Officer affected goods and services involved in interstate commerce.
(h)    Cooperation in Drafting.  Each party has cooperated in the drafting, negotiation and preparation of this Agreement.  Hence, in any construction to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter of such language.
(i)    Counterparts.  This Agreement may be executed in counterparts, and each counterpart, when executed, shall have the efficacy of a signed original.  

9

Photographic or PDF copies of such signed counterparts may be used in lieu of the originals for any purpose.
(j)    No Wrongdoing.  This Agreement constitutes a compromise and settlement of any and all potential disputed claims.  No action taken by either party hereto, either previously or in connection with this Agreement, shall be deemed or construed to be: (a) an admission of the truth or falsity of any potential claims; or (b) an acknowledgment or admission by either party of any fault or liability whatsoever to the other party or to any third party.
(k)    Voluntary Execution of Agreement.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the parties hereto, with the full intent of releasing all claims.  The parties acknowledge that (a) they have read this Agreement; (b) they have had the opportunity to seek legal counsel of their own choice; (c) they understand the terms and consequences of this Agreement and of the releases it contains; and (d) they are fully aware of the legal and binding effect of this Agreement.
(l)    Supplementary Documents.  All parties agree to cooperate fully and to execute any and all supplementary documents and to take all additional actions that may be necessary or appropriate to give full force to the basic terms and intent of this Agreement and which are not inconsistent with its terms. 
(m)    Headings; Construction.  The section and paragraph headings and titles contained in this Agreement are inserted for convenience only, and they neither form a part of this Agreement nor are they to be used in the construction or interpretation of this Agreement.  Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders and the neutral.  Where specific language is used to clarify by example a general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates.
(n)    Taxes.  Except for amounts withheld by the Company, Executive shall be solely responsible for any taxes due as a result of any payments or benefits provided for in this Agreement, other than the Company’s employer portion of social security, Medicare, or any other employment-related tax.  It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Section 409A of the U.S. Internal Revenue Code so as not to subject Executive to payment of any additional tax, penalty or interest imposed under Section 409A, and the provisions of this Agreement shall be construed and interpreted consistent with that intent.
 [Remainder of Page Intentionally Left Blank]

10

I have read the foregoing Separation and Release Agreement and I accept and agree to the provisions it contains and hereby execute it voluntarily with full understanding of its consequences.
EXECUTED this 22nd day of August 2017, at Seattle, Washington.
“Executive”
       /s/ Matthew Plunkett                     
Matthew Plunkett

EXECUTED this 22nd day of August 2017, at Seattle, Washington.
“Company”
CTI BioPharma Corp.

       /s/ Adam Craig                              
By:    Adam Craig
Its:    President and Chief Executive Officer

11

EXHIBIT A
CONSULTING AGREEMENT

August 22, 2017

Matthew Plunkett

Dear Matt:

This letter sets forth our agreement concerning your engagement to provide consulting services to CTI BioPharma Corp., a Washington corporation (the “Company”), on the terms and conditions set forth below, following the termination of your employment with the Company.  

Termination of Employment.  You and the Company hereby agree that your employment with the Company terminated on August 22, 2017 (the “Employment Termination Date”).  In connection with this letter, you and the Company are entering into a Separation and Release Agreement dated on the Employment Termination Date (the “Separation Agreement”).  This letter agreement is contingent upon your timely providing such executed Separation Agreement to the Company and not revoking such agreement or any release set forth therein within any revocation period provided by applicable law or the terms thereof.
By signing this letter, you represent that in your actions undertaken as a Company officer and employee, you acted in good faith and in a manner that you reasonably believed to be in, or not opposed to, the best interests of the Company, and that you had a reasonable belief at all times that your conduct was lawful.  You acknowledge, understand, and agree that the Company is relying on your representation and that this representation is material to the Company in determining whether to enter into this letter.

Engagement; Consulting Fee.  For the period commencing on the Employment Termination Date and continuing through the date that is twelve (12) months after the Employment Termination Date (the “Expiration Date”), subject to the earlier termination and possible extension provisions set forth below (such period, the “Consulting Term”), you agree to provide consulting services of up to ten (10) hours per month to the Company’s Board of Directors and management as they may reasonably request from time to time (the “Services”).  The Services shall primarily involve, but shall not be limited to, providing assistance and advice with respect to matters involving the Company’s business and operations, and the business and operations of the Company’s subsidiaries, in light of your knowledge and experience with the Company.  

You agree to make yourself available to perform the Services as reasonably requested by and as directed by the Company and the Company agrees to reasonably accommodate your schedule in making its requests.  It is acknowledged and agreed that there are no agreements between you and the Company, including, without limitation, this Consulting Agreement, that preclude you from working for other entities and/or individuals during and after the term of this Consulting Agreement.

Consulting Agreement 
Page 1

In consideration for the rendering of the Services, you will receive a consulting fee (the “Consulting Fee”) in the amount of $3,000 per month during the Consulting Term; provided, however, that if you agree to provide Services for more than ten (10) hours in a particular month as authorized by the Company’s Chief Executive Officer, you will be entitled to an additional Consulting Fee for that month equal to $300 per hour for each hour of your Services in excess of 10 hours during that month.  The Consulting Fee for a particular month will be paid by check in a lump sum mailed to you on or within fifteen (15) days following the end of that month.  Notwithstanding anything else contained herein to the contrary, if your Services hereunder terminate for any reason prior to the Expiration Date (or prior to the expiration of any extension of the Consulting Term thereafter elected by the Company as provided above), you will not be entitled to payment of any Consulting Fee for any period after the termination of your Services. 

In addition, the Company may, in its sole discretion, elect to extend the Consulting Term by one or more periods of six (6) months following the Expiration Date, provided the Company provides written notice to you of any such extension not later than thirty (30) days before the expiration of the Consulting Term as then in effect.  If the Company so elects to extend the Consulting Term beyond the Expiration Date set forth above, your Consulting Fee for any Services you perform hereunder after the Expiration Date will equal $300 per hour for such Services.

You agree that (i) you will perform the Services and prepare any work product in a professional manner and in accordance with the best practices in the industry, (ii) you will not include in any work product or otherwise disclose or provide to the Company any confidential information, trade secrets or other proprietary information belonging to a third party, (iii) you are not bound by any employment, consulting, non-compete, confidentiality, trade secret or similar agreement that would be breached or violated by your performance of the Services, and (iv) you will comply with all applicable federal, state and local laws in the course of performing the Services.  You agree to comply with your obligations regarding confidentiality under the Proprietary Information Agreement.  Any confidential information of the Company and its affiliates that you receive during the period you provide the Services will be treated as confidential under the Proprietary Information Agreement, and you agree to hold such information in confidence pursuant to the terms and conditions of the Proprietary Information Agreement to the same extent as if you had received such information during the course of your prior employment with the Company.

You acknowledge that you are not an employee of the Company for any purpose whatsoever, including state and federal taxes and workers’ compensation insurance, but will be acting as an independent contractor with respect to the Services provided to the Company.  You acknowledge that you will maintain your own books and records to reflect all revenue generated by, and costs associated with, your business operations, and are solely responsible for all profits and losses thereto.  The Company will not be responsible for your acts while performing the Services under this letter agreement.  Nothing contained in this letter agreement shall be construed to imply an employment, joint venture, partnership or principal-agent relationship between the parties and neither party by virtue of this agreement shall have any right, power or authority to act or create any obligation, express or implied, on behalf of the other party. 

Consulting Agreement 
Page 2

You understand and agree that the Consulting Fee specified above shall be the entire consideration to be received by you from the Company for the performance of the Services, and that the Consulting Fee shall include any and all taxes and contributions applicable to you.  You shall be responsible for payment of all taxes arising out of your performance of the Services, including but not limited to, federal and state income tax, Social Security tax, unemployment insurance tax, and any other tax or business license fee as required.  Notwithstanding any provision in any stock option or other equity award agreement between you and the Company to the contrary, your equity awards granted by the Company, to the extent outstanding and unvested on the Employment Termination Date (after giving effect to the accelerated vesting of certain options as provided in the Separation Agreement), terminated on such date, and you will not be entitled to any vesting credit as to any such award with respect to the Services.  Any post-termination of service period within which to exercise any stock options granted to you by the Company (including as provided in the Separation Agreement), to the extent such options are outstanding and vested on the Employment Termination Date, commenced on the Employment Termination Date and shall not be tolled or extended by virtue of the Services.

The Company will indemnify you against, and will hold you harmless from, any claim, loss, damage, liability and expense, including reasonable attorney’s fees, court costs and properly incurred expenses, arising out of the Services performed pursuant to this Consulting Agreement; provided, however, that the Company shall have no obligation to indemnify you to the extent such claim, loss, damage, liability or expense results, directly or indirectly, from your gross negligence or willful misconduct.

Termination of Services.  Prior to the expiration of the Consulting Term as then in effect, (a) the Company may terminate the Services and your relationship with the Company for any reason or no reason and (b) you may terminate the Services and your relationship with the Company if the Company breaches the Separation Agreement or this Consulting Agreement.

General.  The validity, interpretation, construction and performance of this letter agreement shall be governed by the laws of the State of Washington without regard to the conflicts of laws principles thereof.  No provision of this letter agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by the party against whom such modification, waiver or discharge is sought to be enforced.  No waiver by either party hereto at any time of any breach by the other party hereto or compliance with any condition or provision of this agreement to be performed by such other party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. If any provision of this letter agreement is adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, and if the rights and obligations of any party under this letter agreement will not be materially and adversely affected thereby, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this letter agreement or affecting the validity or enforceability of such provision in any other jurisdiction, and to this end the provisions of this letter agreement are declared to be severable.  This letter agreement (along with the Separation Agreement (including, but not limited to, Section 11 of the Separation Agreement), and the Proprietary Information Agreement) constitutes the entire agreement of the parties with respect to the subject matter hereof and supersedes any and all prior agreements of the 

Consulting Agreement 
Page 3

parties with respect to such subject matter.  No agreements or representations, oral or otherwise, expressed or implied with respect to the subject matter hereof have been made by either party which are not set forth expressly in this letter agreement (or the documents referred to herein).  This letter agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same agreement. 

Please sign and date the enclosed duplicate where indicated to acknowledge that you have read this letter and agree to comply with its terms, and return the signed copy to me.

[Remainder of Page Intentionally Left Blank]

Consulting Agreement 
Page 4

CTI BIOPHARMA CORP.

       /s/ Adam Craig                              
     Print Name:  Adam Craig 
     Title:  President and Chief Executive Officer

Accepted and Agreed:

By:           /s/ Matthew Plunkett                    
Matthew Plunkett

Consulting Agreement 
Page 5

EXHIBIT B
PROPRIETARY INFORMATION AGREEMENT
PROPRIETARY INFORMATION AND 
INVENTIONS ASSIGNMENT AGREEMENT
As a condition of CTI BioPharma Corp., a Washington corporation (together with its affiliates, successors or assigns, the “Company”) entering into that certain Separation and Release Agreement, dated August 22, 2017, by and between me and the Company (the “Separation Agreement”), and for other good and valuable consideration, the receipt and sufficiency of which I hereby acknowledge, I agree to the following:
1.    Confidential Information.
A.    Company Information.  I agree at all times during the remaining term of my employment and thereafter, to hold in strictest confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of an officer of the Company (other than me), any Company Confidential Information, except under a non-disclosure agreement duly authorized and executed by the Company.  I understand that “Company Confidential Information” means any non-public information that relates to the actual or anticipated business or research and development of the Company; technical data, trade secrets or know-how, including, but not limited to, research, product plans or other information regarding the Company’s products or services and markets therefor; customer lists, contact information, buying history, contract negotiations and preferences (including, but not limited to, customers of the Company on whom I called or with whom I became acquainted during the term of my employment); vendor lists, contact information, and contract negotiations (including, but not limited to, vendors of the Company on whom I called or with whom I became acquainted during the term of my employment); personnel information (including information regarding other employees’ skills, performance, discipline and compensation); software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information; marketing, pricing, and financing information, plans and strategies; finances or other business information.  I further understand that Company Confidential Information does not include any of the foregoing items that have become publicly known and made generally available through no act of mine or of others who were under confidentiality obligations as to the item or items involved or improvements or new versions thereof. I understand that nothing in this Agreement is intended to limit employees’ rights to discuss the terms, wages, and working conditions of their employment, as protected by applicable law.
B.    Third-Party Information.  I recognize that the Company has received and in the future will receive from third parties associated with the Company, e.g., the Company’s customers, suppliers, licensors, licensees, partners, or collaborators (“Associated Third Parties”) their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes 

Proprietary Information Agreement 
Page 1

(“Associated Third-Party Confidential Information”).  By way of example, Associated Third-Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties, and information related to the business conducted between the Company and such Associated Third Parties.  I agree at all times during my employment with the Company and thereafter to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with the Company’s agreement with such Associated Third Parties.
C.    EU Personal Data.  During my employment with the Company, I have had access to and may continue to have access to individually identifying information about Company employees, contractors and third-party workers in European Union countries (collectively, “EU Personal Data”).  I will access EU Personal Data only when I have a legitimate and necessary business reason to do so.  I further agree to strictly maintain the confidentiality of EU Personal Data.
D.    Immunity.  Pursuant to the Defend Trade Secrets Act of 2016, I acknowledge that I may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed in a lawsuit or other proceeding, provided that such filing is made under seal.  Further, I understand that the Company will not retaliate against me in any way for any such disclosure made in accordance with the law.  In the event a disclosure is made, and I file any type of proceeding against the Company alleging that the Company retaliated against me because of my disclosure, I may disclose the relevant trade secret to my attorney and may use the trade secret in the proceeding if (i) I file any document containing the trade secret under seal, and (ii) I do not otherwise disclose the trade secret except pursuant to court or arbitral order.  
2.    Inventions.
A.    Inventions Retained and Licensed.  I represent that there are no inventions, original works of authorship, developments, improvements or trade secrets that were made by me prior to my employment with the Company (collectively referred to as “Prior Inventions”) that relate in any way to the Company’s business, products or research and development, and that are not assigned to the Company hereunder.  If in the course of my employment with the Company, I incorporated into a Company product, process or service a Prior Invention owned by me or in which I have an interest, I hereby grant to the Company, effective as of the date of such incorporation, a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide, sublicensable (through one or more tiers of sublicensees), transferable license to make, have made,  use, import, offer for sale, sell, create Derivative Works (as such term is defined in the United States Copyright Act) of, distribute, publicly display and publicly perform such Prior Invention as part of or in connection with such product, process, service, technology or other work, and to practice any method related thereto.   

Proprietary Information Agreement 
Page 2

B.    Assignment of Inventions.  I agree that I hereby assign and will assign to the Company, or its designee, all my right, title and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registrable under copyright or similar laws, that I may have solely or jointly conceived or developed or reduced to practice, or caused to be conceived or developed or reduced to practice, or that I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time I am in the employ of the Company (whether before or after the execution of this Agreement and including during “off-duty” hours) (collectively referred to as “Inventions”).  I further acknowledge that all original works of authorship that have been and are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Company (whether before or after the execution of this Agreement) and which are protectable by copyright are “works made for hire,” as that term is defined in the United States Copyright Act.  I understand and agree that the decision whether or not to commercialize or market any invention developed by me solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty or other compensation will be due to me as a result of the Company’s efforts to commercialize or market any such Invention.  I hereby waive and agree never to assert any Moral Rights in or with respect to any and all of the Inventions that may exist anywhere in the world, together with all claims for damages and other remedies asserted on the basis of Moral Rights.  “Moral Rights” means any right to claim authorship to or to object to any distortion, mutilation, or other modification or other derogatory action in relation to a work, whether or not such action would be prejudicial to the author’s reputation, and any similar right, existing under common or statutory law of any country in the world or under any treaty, regardless of whether or not such right is denominated or generally referred to as a “moral right.”
C.    Inventions Assigned to the United States.  I agree to assign to the United States government all my right, title and interest in and to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its agencies.
D.    Maintenance of Records.  I agree to keep and maintain adequate and current written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the Company.  The records will be in the form of notes, sketches, drawings and any other format that may be specified by the Company.  The records will be available to, and remain the sole property of, the Company at all times, and I will deliver same to the Company upon request.
E.    Patent and Copyright Registrations.  I agree to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, 

Proprietary Information Agreement 
Page 3

assigns and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto.  I further agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the termination of my employment with the Company.  If the Company is unable because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications, specifications, oaths, assignments and other instruments and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by me.
F.    Exception to Assignments.  
(1)    I understand that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply to any Invention which is covered, according to applicable law, under the provisions of California Labor Code Section 2870 (attached hereto as Appendix A).  I will advise the Company promptly in writing of any inventions that I believe meet the criteria in California Labor Code Section 2870.  However, I represent and agree that through the date of this Agreement no invention meets the criteria in California Labor Code Section 2870.  I represent that, as of the date hereof, there are no such Inventions.  
(2)    Consistent with Washington state law, RCW § 49.44.140, the Company is required by law to inform me that this Agreement does not apply to an Invention for which no equipment, supplies, facility, or trade secret information of the Company’s was used and which was developed entirely on my own time, unless (a) the Invention relates (i) directly to the business of the Company, or (ii) to the Company’s actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by me for the Company. However, even considering the above, the assignment of rights to the Company is still valid, if (a) the Invention relates either directly to the business of the Company or its actual or demonstrably anticipated research or development, or (b) the Invention results from any work performed by me for the Company. Additionally, RCW § 49.44.150 mandates, and I further agree that, at the time of employment or at any time after, I must and shall disclose all Inventions being developed by me (or my related companies or related entities), for the purpose of determining my rights or their rights.  I acknowledge and agree that this Agreement constitutes the Company’s notice to me as to the foregoing required by RCW § 49.44.140.  I represent that, as of the date hereof, (a) there are no Inventions for which no equipment, supplies, facility, or trade secret information of the Company’s was used and which was developed entirely on my own time, and (b) any and all Inventions fall within clause (a) and/or (b) of the first sentence of this Section 2.F(2).

Proprietary Information Agreement 
Page 4

G.    Social Media and Online Accounts.  I agree that I have not and will not register or cause to be registered any social media account or other online account using the Company name or marks or for use by or on behalf of the Company except using a Company email address and, if applicable, a Company telephone number, and that all such accounts are the sole property of the Company.  I agree to provide to the Company upon request, whether before or after the termination of my employment with the Company, all credentials associated with such accounts.
3.    Termination Certification.  I agree to keep the Company advised of my home and business address for a period of three (3) years after termination of my employment with the Company, so that the Company can contact me regarding my continuing obligations provided by this Agreement.
4.    Notification of New Employer.  I hereby grant consent to the Company to notify any new employer that I may have about my rights and obligations under this Agreement.
5.    Use of My Image.  I hereby grant the Company permission to use any images taken of me by or on behalf of the Company during my employment with the Company for commercial or non-commercial materials and collateral, including, but not limited to, the Company’s websites, publicly-filed documents, presentations, signage and advertisements.  I understand that I will not receive any additional compensation for such use and hereby release the Company and anyone working on behalf of the Company in connection with the use of my images.
6.    Representations.  I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement.  I represent that my performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Company.  I hereby represent and warrant that I have not entered into, and I will not enter into, any oral or written agreement in conflict herewith.
7.    Audit.  I acknowledge that I have no reasonable expectation of privacy in any computer, technology system, email, handheld device, telephone, or documents that are owned by the Company and that are used to conduct the business of the Company.  As such, the Company has the right to audit and search all such items and systems, without further notice to me, to ensure that the Company is licensed to use the software on the Company’s devices in compliance with the Company’s software licensing policies, to ensure compliance with the Company’s policies, and for any other business-related purposes in the Company’s sole discretion.  I understand that I am not permitted to add any unlicensed, unauthorized, or non-compliant applications to the Company’s technology systems and that I shall refrain from copying unlicensed software onto the Company’s technology systems or using non-licensed software or websites.  I understand that it is my responsibility to comply with the Company’s policies governing use of the Company’s documents and the internet, email, telephone, and technology systems to which I will have access in connection with my employment. By entering into this Agreement, however, I am not giving the Company my permission to audit or search any item or system owned by me personally.

Proprietary Information Agreement 
Page 5

8.    Arbitration and Equitable Relief.
A.    I agree to arbitrate any disputes between us that might otherwise be resolved in a court of law under the arbitration provisions of Section 11 of the Separation Agreement,  except as otherwise provided herein or to the extent prohibited by applicable law and in accordance with the Federal Arbitration Act. I acknowledge that this Agreement is governed by the Federal Arbitration Act and evidences a transaction involving commerce.
B.    Notwithstanding the parties’ agreement to submit all disputes to final and binding arbitration, and notwithstanding anything in Section 11 of the Separation Agreement to the contrary, either party may file an action in any court of competent jurisdiction to seek and obtain provisional injunctive and/or equitable relief to ensure that any relief sought in arbitration is not rendered ineffectual by interim harm that could occur during the pendency of the arbitration proceeding related to any alleged violation of this Agreement.  The Company and I agree that any party may petition the court for provisional injunctive relief, and seek permanent injunctive relief from the Arbitrator, where either party alleges or claims a violation of this Agreement or any provision of any other agreement regarding trade secrets, assignment of inventions, confidential information, non-competition or non-solicitation.  The parties each understand that any breach or threatened breach of this Agreement or any such other provision will cause irreparable injury and that money damages will not provide an adequate remedy therefor and both parties hereby consent to the issuance of a provisional and/or permanent injunction.
C.    By signing below, I acknowledge and agree that I am executing this Agreement, including this arbitration provision, voluntarily and without any duress or undue influence by the Company or anyone else. I have carefully read the provisions of this Agreement and understand the terms, consequences, and binding effect of these provisions, including that I am waiving any right to a jury trial. I further acknowledge that I have been provided an opportunity to seek legal counsel of my choosing before executing this Agreement.
9.    General Provisions.
A.    Governing Law; Consent to Personal Jurisdiction.  This Agreement will be governed by the laws of the State of Washington without regard to the conflict of law provisions thereof.  I hereby expressly consent to the personal jurisdiction of the state and federal courts located in the State of Washington for any lawsuit filed there against me by the Company arising from or relating to this Agreement.
B.    Construction.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing signed by an officer of the Company (other than me) and me.  I acknowledge and agree that I am executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else. This Agreement will not be construed in favor of or against either party hereto.  Nothing in this Agreement will be construed to limit my obligations under any prior agreement between the Company and me with similar subject matter hereto.

Proprietary Information Agreement 
Page 6

C.    Severability.  If one or more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in full force and effect.
D.    Successors and Assigns.  This Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors and its assigns.
[Remainder of Page Intentionally Left Blank]

Proprietary Information Agreement 
Page 7

		
	Date: August 22, 2017                            
	    /s/ Matthew Plunkett             
Matthew Plunkett

CTI BIOPHARMA CORP.

By:      /s/ Adam Craig            
Name:  Adam Craig
Its:    President and Chief 
    Executive Officer

Proprietary Information Agreement 
Page 8

APPENDIX A
CALIFORNIA LABOR CODE SECTION 2870 
INVENTION ON OWN TIME-EXEMPTION FROM AGREEMENT
“(a)    Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either:
(1)    Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or
(2)    Result from any work performed by the employee for the employer.
(b)    To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.”

Proprietary Information Agreement 
Appendix AExhibit

IPALCO ENTERPRISES, INC. 
as Issuer
and
U.S. Bank National Association, 
as Trustee
__________________________________
Indenture
__________________________________
Dated as of August 22, 2017
__________________________________
3.70% Senior Secured Notes Due 2024

US-DOCS\92684268.3

	
				
	TABLE OF CONTENTS

	 

	ARTICLE 1

	 

	DEFINITIONS AND INCORPORATION BY REFERENCE

	 
	 
	 
	 

	SECTION 1.01
	 
	Definitions
	1

	SECTION 1.02
	 
	Rules of Construction
	12

	 
	 
	 
	 

	ARTICLE 2

	 
	 
	 
	 

	THE NOTES

	 
	 
	 
	 

	SECTION 2.01
	 
	Form, Dating and Denominations; Legends
	12

	SECTION 2.02
	 
	Execution and Authentication; Additional Notes
	13

	SECTION 2.03
	 
	Registrar, Paying Agent and Authenticating Agent; Paying Agent to
	 

	 
	 
	     Hold Money in Trust
	14

	SECTION 2.04
	 
	Replacement Notes
	15

	SECTION 2.05
	 
	Outstanding Notes
	15

	SECTION 2.06
	 
	Temporary Notes
	15

	SECTION 2.07
	 
	Cancellation
	16

	SECTION 2.08
	 
	CUSIP and CINS Numbers
	16

	SECTION 2.09
	 
	Registration, Transfer and Exchange
	16

	SECTION 2.10
	 
	Restrictions on Transfer and Exchange
	19

	SECTION 2.11
	 
	Temporary Offshore Global Notes
	20

	 
	 
	 
	 

	ARTICLE 3

	 
	 
	 
	 

	OPTIONAL REDEMPTION

	 
	 
	 
	 

	SECTION 3.01
	 
	Optional Redemption
	21

	SECTION 3.02
	 
	Method and Effect of Redemption
	21

	SECTION 3.03
	 
	Sinking Fund
	22

	 
	 
	 
	 

	ARTICLE 4

	 
	 
	 
	 

	COVENANTS

	 
	 
	 
	 

	SECTION 4.01
	 
	Payment of Notes
	23

	SECTION 4.02
	 
	Maintenance of Office or Agency
	23

	SECTION 4.03
	 
	Limitations on Liens
	24

	SECTION 4.04
	 
	Noteholders' Lists
	27

	SECTION 4.05
	 
	Certificate to Trustee
	27

	SECTION 4.06
	 
	Reports by the Company
	27

	SECTION 4.07
	 
	Repurchase of Notes Upon a Change of Control
	28

	 
	 
	 
	 

i

	
				
	ARTICLE 5

	 
	 
	 
	 

	CONSOLIDATION, MERGER OR SALE OF ASSETS

	 
	 
	 
	 

	SECTION 5.01
	 
	Limitations on Merger, Consolidation, Sale, Lease or Conveyance
	28

	SECTION 5.02
	 
	Successor Substituted
	29

	 
	 
	 
	 

	ARTICLE 6

	 
	 
	 
	 

	DEFAULT AND REMEDIES

	 
	 
	 
	 

	SECTION 6.01
	 
	Events of Default
	30

	SECTION 6.02
	 
	Acceleration
	31

	SECTION 6.03
	 
	Other Remedies
	31

	SECTION 6.04
	 
	Waiver of Past Defaults
	31

	SECTION 6.05
	 
	Control by Majority
	32

	SECTION 6.06
	 
	Limitation on Suits
	32

	SECTION 6.07
	 
	Rights of Holders to Receive Payment
	32

	SECTION 6.08
	 
	Collection Suit by Trustee
	32

	SECTION 6.09
	 
	Trustee May File Proofs of Claim
	33

	SECTION 6.10
	 
	Priorities
	33

	SECTION 6.11
	 
	Restoration of Rights and Remedies
	33

	SECTION 6.12
	 
	Undertaking for Costs
	34

	SECTION 6.13
	 
	Rights and Remedies Cumulative
	34

	SECTION 6.14
	 
	Delay or Omission Not Waiver
	34

	SECTION 6.15
	 
	Waiver of Stay, Extension or Usury Laws
	34

	 
	 
	 
	 

	ARTICLE 7

	 
	 
	 
	 

	THE TRUSTEE

	 
	 
	 
	 

	SECTION 7.01
	 
	General
	34

	SECTION 7.02
	 
	Certain Rights of Trustee
	35

	SECTION 7.03
	 
	Individual Rights of Trustee
	37

	SECTION 7.04
	 
	Trustee's Disclaimer
	37

	SECTION 7.05
	 
	Notice of Default
	37

	SECTION 7.06
	 
	Reports by Trustee to Holders
	38

	SECTION 7.07
	 
	Compensation and Indemnity
	38

	SECTION 7.08
	 
	Replacement of Trustee
	38

	SECTION 7.09
	 
	Successor Trustee by Merger
	39

	SECTION 7.10
	 
	Eligibility
	40

	SECTION 7.11
	 
	Money Held in Trust
	40

	 
	 
	 
	 

	ARTICLE 8

	 
	 
	 
	 

	DEFEASANCE AND DISCHARGE 

ii

	
				
	 
	 
	 
	 

	SECTION 8.01
	 
	Satisfaction and Discharge of Indenture
	40

	SECTION 8.02
	 
	Defeasance and Discharge of Indenture
	41

	SECTION 8.03
	 
	Defeasance of Certain Obligations
	42

	SECTION 8.04
	 
	Application of Trust Money
	43

	SECTION 8.05
	 
	Repayment to Company
	44

	SECTION 8.06
	 
	Reinstatement
	44

	 
	 
	 
	 

	ARTICLE 9

	 
	 
	 
	 

	AMENDMENTS, SUPPLEMENTS AND WAIVERS

	 
	 
	 
	 

	SECTION 9.01
	 
	Amendments Without Consent of Holders
	44

	SECTION 9.02
	 
	Amendments With Consent of Holders
	45

	SECTION 9.03
	 
	Effect of Consent
	46

	SECTION 9.04
	 
	Trustee's Rights and Obligations
	46

	SECTION 9.05
	 
	Conformity with Trust Indenture Act
	46

	SECTION 9.06
	 
	Payments for Consents
	46

	 
	 
	 
	 

	ARTICLE 10

	 
	 
	 
	 

	MISCELLANEOUS

	 
	 
	 
	 

	SECTION 10.01
	 
	Trust Indenture Act of 1939
	47

	SECTION 10.02
	 
	Noteholder Communications; Noteholder Actions
	47

	SECTION 10.03
	 
	Notices
	47

	SECTION 10.04
	 
	Certificate and Opinion as to Conditions Precedent
	48

	SECTION 10.05
	 
	Statements Required in Certificate or Opinion
	48

	SECTION 10.06
	 
	Payment Date Other Than a Business Day
	49

	SECTION 10.07
	 
	Governing Law
	49

	SECTION 10.08
	 
	No Adverse Interpretation of Other Agreements
	49

	SECTION 10.09
	 
	Successors
	49

	SECTION 10.10
	 
	Duplicate Originals
	49

	SECTION 10.11
	 
	Seperability
	49

	SECTION 10.12
	 
	Table of Contents and Headings
	49

	SECTION 10.13
	 
	No Liability of Directors, Officers, Employees, Incorporators and
	 

	 
	 
	     Stockholders
	49

	SECTION 10.14
	 
	Waiver of Jury Trial
	50

	SECTION 10.15
	 
	Force Majeure
	50

	 
	 
	 
	 

	ARTICLE 10

	 
	 
	 
	 

	MISCELLANEOUS

	 
	 
	 
	 

	SECTION 11.01
	 
	Pledge Agreement
	50

	SECTION 11.02
	 
	Recording and Opinions
	51

iii

	
				
	SECTION 11.03
	 
	Release of Collateral
	51

	SECTION 11.04
	 
	Certificates of the Company
	51

	SECTION 11.05
	 
	Certificates of the Trustee
	52

	SECTION 11.06
	 
	Authorization of Actions To Be Taken by the Collateral Agent Under
	 

	 
	 
	     the Pledge Agreement
	52

	SECTION 11.07
	 
	Authorization of Receipt of Refunds by the Trustee Under the Pledge
	 

	 
	 
	     Agreement
	52

	SECTION 11.08
	 
	Termination of Security Interest
	 

	 
	 
	 
	 

	EXHIBITS
	 
	 
	 

	 
	 
	 
	 

	EXHIBIT A
	 
	Form of Note
	 

	EXHIBIT B
	 
	Restricted Legend
	 

	EXHIBIT C
	 
	DTC Legend
	 

	EXHIBIT D
	 
	Regulation S Certificate
	 

	EXHIBIT E
	 
	Rule 144A Certificate
	 

	EXHIBIT F
	 
	Certificate of Beneficial Ownership
	 

	EXHIBIT G
	 
	Temporary Offshore Global Note Legend
	 

	 
	 
	 
	 

iv

INDENTURE, dated as of August 22, 2017, between IPALCO Enterprises, Inc., an Indiana corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
RECITALS
The Company has duly authorized the execution and delivery of the Indenture to provide for the issuance of senior secured notes, designated as the “3.70% Senior Secured Notes due 2024” in an aggregate principal amount of $405,000,000 (collectively with, if and when issued, any Additional Notes, the “Notes”).  All things necessary to make the Indenture a legal, valid and binding agreement of the Company, in accordance with its terms, have been done, and the Company has done all things necessary to make the Notes (in the case of the Additional Notes, when duly authorized), when executed by the Company and authenticated and delivered by the Trustee and duly issued by the Company, the legal, valid and binding obligations of the Company as hereinafter provided.
This Indenture is subject to, and will be governed by, the provisions of the Trust Indenture Act that are required to be a part of and govern indentures qualified under the Trust Indenture Act.
THIS INDENTURE WITNESSETH
For and in consideration of the premises and the purchase of the Notes by the Holders thereof, the parties hereto covenant and agree, for the equal and proportionate benefit of all Holders, as follows:

ARTICLE 1 
DEFINITIONS AND INCORPORATION BY REFERENCE

SECTION 1.01    Definitions.  Unless otherwise noted, the definitions herein apply to both the singular and plural meanings of each term.
“Additional Notes” means any Notes issued under the Indenture in addition to the Initial Notes having the same terms in all respects as the Initial Notes.
“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under direct or indirect common control with, such Person.  For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”) with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.
“Agent” means any Registrar, Paying Agent or Authenticating Agent.

“Agent Member” means a member of, or a participant in, the Depositary.
“Authenticating Agent” refers to a Person engaged to authenticate the Notes in the stead of the Trustee.
“Bankruptcy Default” has the meaning assigned to such term in Section 6.01.
“Board of Directors” of a Person means the board of directors or comparable governing body of such Person.
“Business Day” means any day except a Saturday, Sunday or other day on which commercial banks in New York City or in the city where the Corporate Trust Office of the Trustee is located are authorized by law to close.
“Capitalized Lease Obligations” means all lease obligations of the Company and its Subsidiaries which, under GAAP, are or will be required to be capitalized, in each case taken at the amount of the lease obligation accounted for as indebtedness in conformity with those principles.
“Certificate of Beneficial Ownership” means a certificate substantially in the form of Exhibit F.
“Certificated Note” means a Note in registered individual form without interest coupons.
“Change of Control” means the occurrence of any of the following:  (1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Company and its subsidiaries taken as a whole to any person (as such term is used in Section 13(d) of the Exchange Act) other than the Company or one of its subsidiaries; (2) the consummation of any transaction (including, without limitation, any merger or consolidation), other than any transaction the result of which is a Parent Company Change of Control, the result of which is that any person (as such term is used in Section 13(d) of the Exchange Act) other than a Permitted Holder becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of the Company’s Voting Stock; or (3) the first day on which a majority of the members of the Company’s Board of Directors are not Continuing Directors of the Company.
“Change of Control Offer” has the meaning assigned to such term in Section 4.07.
“Change of Control Payment” has the meaning assigned to such term in Section 4.07.
“Change of Control Triggering Event” means the occurrence of a Rating Event and either (a) a Change of Control, or (b) a Parent Company Change of Control.

2

“Clearstream” means Clearstream Banking S.A. and its successors.
“Collateral” has the meaning specified in the Pledge Agreement.
“Collateral Agent” has the meaning specified in the Pledge Agreement.
“Commission” means the Securities and Exchange Commission.
“Company” means the party named as such in the first paragraph of the Indenture or any successor obligor under the Indenture and the Notes pursuant to Section 5.01.
“Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to the remaining term of the notes to be redeemed (assuming, for this purpose, that such notes matured on the Par Call Date) that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the notes.
“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of five Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Company obtains fewer than five such Reference Treasury Dealer Quotations, the average of all such quotations.
“Continuing Directors” means, as of any date of determination, any member of the Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the Notes; or (2) was nominated for election or elected to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by vote of the Board of Directors or by approval of the stockholders after receipt of a proxy statement in which such member was named as a nominee for election as a director, without objection to such nomination).
“Corporate Trust Office” means the corporate trust office of the Trustee at which at any time its corporate trust business with respect to this Indenture shall be administered, which office at the dated hereof is located at U.S. Bank National Association, 10 West Market Street, Suite 1150, Indianapolis, IN 46204, Attention: Global Corporate Trust Services, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).
“Currency, Interest Rate or Commodity Agreements” means an agreement or transaction involving any currency, interest rate or Energy price or volumetric swap, cap or collar arrangement, forward exchange transaction, option, warrant, forward rate agreement, futures contract or other derivative instrument of any kind for the hedging or management of foreign exchange, interest rate or Energy price or volumetric risks, it being understood, for purposes of 

3

this definition, that the term “Energy” will include, without limitation, coal, gas, oil and electricity.
“Default” means any event that is, or after notice or passage of time or both would be, an Event of Default.
“Depositary” means the depositary of each Global Note, which will initially be DTC.
“DTC” means The Depository Trust Company, a New York corporation, and its successors.
“DTC Legend” means the legend set forth in Exhibit C.
“Euroclear” means Euroclear Bank S.A./N.V., and its successors or assigns, as operator of the Euroclear System.
“Event of Default” has the meaning assigned to such term in Section 6.01.
“Exchange Act” means the Securities Exchange Act of 1934.
“Excluded Subsidiary” means any Subsidiary of the Company:
(1)    in respect of which neither the Company nor any Subsidiary of the Company (other than another Excluded Subsidiary) has undertaken any legal obligation to give any guarantee for the benefit of the holders of any Indebtedness for Borrowed Money (other than to another member of the Group) other than in respect of any statutory obligation and the Subsidiaries of which are all Excluded Subsidiaries; and
(2)    which has been designated as such by the Company by written notice to the Trustee; provided that the Company may give written notice to the Trustee at any time that any Excluded Subsidiary is no longer an Excluded Subsidiary whereupon it shall cease to be an Excluded Subsidiary.
“Fitch” means Fitch Ratings, Inc.
“GAAP” means generally accepted accounting principles in the United States of America as in effect from time to time.
“Global Note” means a Note in registered global form without interest coupons.
“Group” means the Company and its Subsidiaries and “member of the Group” shall be construed accordingly.
“Holder” or “Noteholder” means the registered holder of any Note.
“Incur” means, with respect to any Indebtedness, to Incur, create, issue, assume or guarantee or otherwise become liable for such Indebtedness; provided that neither the accrual 

4

of interest (whether such interest is payable in cash or in kind) nor the accretion of original issue discount shall be considered an “Incurrence” of Indebtedness.
“Indebtedness” means, with respect to the Company or any of its Subsidiaries at any date of determination (without duplication):
(1)    all Indebtedness for Borrowed Money (excluding any credit which is available but undrawn);
(2)    all obligations in respect of letters of credit (including reimbursement obligations with respect to letters of credit);
(3)    all obligations to pay the deferred and unpaid purchase price of property or services, which purchase price is due more than six months after the date of placing such property in service or taking delivery and title to the property or the completion of such services, except trade payables;
(4)    all Capitalized Lease Obligations;
(5)    all indebtedness of other persons secured by a mortgage, charge, lien, pledge or other security interest on any asset of the Company or any of its Subsidiaries, whether or not such indebtedness is assumed; provided that the amount of such Indebtedness must be the lesser of: (a) the fair market value of such asset at such date of determination and (b) the amount of the secured indebtedness;
(6)    all indebtedness of other persons of the types specified in the preceding clauses (1) through (5), to the extent such indebtedness is guaranteed by the Company or any of its Subsidiaries; and
(7)    to the extent not otherwise included in this definition, net obligations under Currency, Interest Rate or Commodity Agreements.
The amount of Indebtedness at any date will be the outstanding balance at such date of all unconditional obligations as described above and, upon the occurrence of the contingency giving rise to the obligation, the maximum liability of any contingent obligations of the types specified in the preceding clauses (1) through (7) at such date; provided that the amount outstanding at any time of any Indebtedness issued with original issue discount is the face amount of such Indebtedness less the remaining unamortized portion of the original issue discount of such Indebtedness at such time as determined in conformity with GAAP.
“Indebtedness for Borrowed Money” means any indebtedness (whether being principal, premium, interest or other amounts) for:
(1)    money borrowed;
(2)    payment obligations under or in respect of any trade acceptance or trade acceptance credit; or

5

(3)    any notes, bonds, loan stock or other debt securities offered, issued or distributed whether by way of public offer, private placement, acquisition consideration or otherwise and whether issued for cash or in whole or in part for a consideration other than cash;
provided, however, in each case, that such term will exclude:
(a)    any indebtedness relating to any accounts receivable securitizations;
(b)    any Indebtedness of the type permitted to be secured by Liens pursuant to Section 4.03(b)(xii) hereof; and
(c)    any Preferred Securities which are issued and outstanding on the date of original issue of the Notes or any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of any such existing Preferred Securities, for amounts not exceeding the principal amount or liquidation preference of the Preferred Securities so extended, renewed or replaced.
“Indenture” means this indenture, as amended or supplemented from time to time.
“Initial Notes” means the Notes issued on the Issue Date and any Notes issued in replacement thereof.
“Initial Purchasers” means the initial purchasers party to a purchase agreement with the Company relating to the sale of the Initial Notes or Additional Notes by the Company.
“Interest Payment Date” has the meaning ascribed to such term in the Notes.
“IPALCO Indebtedness” means any Indebtedness of the Company; provided that the aggregate outstanding principal amount of such Indebtedness that is secured by a Lien upon any common stock of IPL may not exceed $1.4 billion and that the proceeds of such secured Indebtedness (other than of any such secured Indebtedness existing prior to the date hereof) may not be used to pay any dividend to the Parent Company and, provided further, that the aggregate outstanding principal amount of such Indebtedness shall be calculated exclusive of secured Indebtedness that is being concurrently redeemed, repaid, defeased or otherwise retired with the proceeds of an offering of secured Indebtedness.
“IPL” means Indianapolis Power & Light Company, an Indiana corporation and a Subsidiary of the Company.
“Issue Date” means the date on which the Initial Notes are originally issued under the Indenture.
“Lien” means any mortgage, lien, pledge, security interest or other encumbrance; provided, however, that the term “Lien” does not mean any easements, rights-of-way, restrictions 

6

and other similar encumbrances and encumbrances consisting of zoning restrictions, leases, subleases, restrictions on the use of property or defects in title.
“Moody’s” means Moody’s Investors Service, Inc.
“Non-U.S. Person” means a Person that is not a U.S. person, as defined in Regulation S.
“Notes” has the meaning assigned to such term in the Recitals.
“Obligations” has the meaning specified in Section 11.01.
“Officer” means the chairman of the Board of Directors, the president or chief executive officer, any vice president, the chief financial officer, the treasurer or any assistant treasurer, or the secretary or any assistant secretary, of the Company.
“Officers’ Certificate” means a certificate signed in the name of the Company (i) by the chairman of the Board of Directors, the president, chief executive officer or chief financial officer or a vice president and (ii) by the treasurer or any assistant treasurer, the secretary or any assistant secretary or the controller.
“Offshore Global Note” means a Global Note representing Notes issued and sold pursuant to Regulation S.
“Opinion of Counsel” means a written opinion signed by legal counsel, who may be an employee of or counsel to the Company.
“Par Call Date” means July 1, 2024, the date that is two months prior to the maturity date of the notes.
“Parent Company” means The AES Corporation, a Delaware Corporation.
“Parent Company Change of Control” means the occurrence of any of the following: (1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Parent Company and its subsidiaries taken as a whole to any person (as such term is used in Section 13(d) of the Exchange Act) other than the Parent Company or one of its subsidiaries; (2) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person (as such term is used in Section 13(d) of the Exchange Act) becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of the Parent Company’s Voting Stock; or (3) the first day on which a majority of the members of the Parent Company’s Board of Directors are not Continuing Directors of the Parent Company.
“Paying Agent” refers to a Person engaged to perform the obligations of the Trustee in respect of payments made or funds held hereunder in respect of the Notes.

7

“Permanent Offshore Global Note” means an Offshore Global Note that does not bear the Temporary Offshore Global Note Legend.
“Permitted Holder” means, at any time, the Parent Company and its affiliates.  In addition, any person or group whose acquisition of beneficial ownership constitutes a Change of Control in respect of which a Change of Control Offer is made in accordance with the requirements of the Indenture will thereafter, together with its affiliates, constitute an additional Permitted Holder.
“Person” means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other entity, including a government or political subdivision or an agency or instrumentality thereof.
“Pledge Agreement” means the Pledge Agreement dated as of November 14, 2001 (as supplemented by the pledge agreement supplement dated April 15, 2008, the pledge agreement supplement dated May 18, 2011, the pledge agreement supplement dated June 25, 2015, the Pledge Agreement Supplement and as the same has been and may hereafter be supplemented by any other pledge agreement supplement or otherwise amended or modified) made by the Company in favor of The Bank of New York Mellon Trust Company, N.A., as Collateral Agent.
“Pledge Agreement Supplement” means the supplement, dated the date hereof, to the Pledge Agreement.
“Pledged Stock” means all of the outstanding common stock of IPL and any proceeds therefrom pledged by the Company to the Collateral Agent for the benefit of the Holders of the Notes.
“Preferred Securities” means, without duplication, any trust preferred or preferred securities or related debt or guaranties of the Company or any of its Subsidiaries.
“Project Finance Debt” means:
(1)    any Indebtedness to finance or refinance the ownership, acquisition, development, design, engineering, procurement, construction, servicing, management and/or operation of any project or asset which is Incurred by an Excluded Subsidiary; and
(2)    any Indebtedness to finance or refinance the ownership, acquisition, development, design, engineering, procurement, construction, servicing, management and/or operation of any project or asset in respect of which the person or persons to whom any such Indebtedness is or may be owed by the relevant borrower (whether or not a member of the Group) has or have no recourse whatsoever to any member of the Group (other than an Excluded Subsidiary) for the repayment of that Indebtedness other than: (a) recourse to such member of the Group for amounts limited to the cash flow or net cash flow (other than historic cash flow or historic net cash flow) 

8

from, or ownership interests or other investments in, such project or asset; and/or (b) recourse to such member of the Group for the purpose only of enabling amounts to be claimed in respect of such Indebtedness in an enforcement of any encumbrance given by such member of the Group over such project or asset or the income, cash flow or other proceeds deriving from the project (or given by any shareholder or the like, or other investor in, the borrower or in the owner of such project or asset over its shares or the like in the capital of, or other investment in, the borrower or in the owner of such project or asset) to secure such Indebtedness, provided that the extent of such recourse to such member of the Group is limited solely to the amount of any recoveries made on any such enforcement; and/or (c) recourse to such borrower generally, or directly or indirectly to a member of the Group, under any form of assurance, indemnity, undertaking or support, which recourse is limited to a claim for damages (other than liquidated damages and damages required to be calculated in a specified way) for breach of an obligation (not being a payment obligation or an obligation to procure payment by another or an indemnity in respect of a payment obligation, or any obligation to comply or to procure compliance by another with any financial ratios or other tests of financial condition) by the person against which such recourse is available.
“Quotation Agent” means any Reference Treasury Dealer appointed by the Company.
“Rating Agencies” means (a) each of Fitch, Moody’s and S&P, and (b) if any of Fitch, Moody’s or S&P ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of our control, a “nationally recognized statistical rating organization” (within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act) selected by the Company as a replacement Rating Agency for a former Rating Agency.
“Rating Event” means (x) the rating on the Notes is lowered and (y) the Notes are rated below an investment grade rating, in either case, by two of the three Rating Agencies on any day within the period (the “Trigger Period”) commencing on the earlier of (a) the occurrence of a Change of Control or a Parent Company Change of Control and (b) public notice of the occurrence of a Change of Control or a Parent Company Change of Control or our intention to effect a Change of Control or the Parent Company’s intention to effect a Parent Company Change of Control and ending 60 days following the consummation of such Change of Control or Parent Company Change of Control (which Trigger Period will be extended so long as the rating of the Notes is under publicly announced consideration for a possible downgrade by any of the Rating Agencies); provided, however, that a Rating Event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control or a particular Parent Company Change of Control (and thus will not be deemed a Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agency making the reduction in rating to which this definition would otherwise apply publicly announces or informs the Trustee in writing at the Company’s request that the reduction was not the result, in whole or in part, of any event or circumstance comprised of or arising as a 

9

result of, or in respect of, the applicable Change of Control or Parent Company Change of Control (whether or not the applicable Change of Control or Parent Company Change of Control has occurred at the time of the Rating Event).
“Redemption Price” has the meaning assigned to such term in Section 3.01.
“Reference Treasury Dealer” means (i) Morgan Stanley & Co. (or its affiliate that is a Primary Treasury Dealer) and its successors; provided, however, that if the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealers selected by the Company.
“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date.
“Register” has the meaning assigned to such term in Section 2.09.
“Registrar” means a Person engaged to maintain the Register.
“Regular Record Date” for the interest payable on any Interest Payment Date means the close of business on February 15 or August 15 (whether or not a Business Day) immediately preceding such Interest Payment Date.
“Regulation S” means Regulation S under the Securities Act.
“Regulation S Certificate” means a certificate substantially in the form of Exhibit D hereto.
“Responsible Officer”, when used with respect to the Trustee, means any officer within the Corporate Trust Office, including any vice president, assistant vice president, assistant secretary (if any), treasurer, assistant treasurer or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers; and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such officer’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.
“Restricted Legend” means the legend set forth in Exhibit B.
“Restricted Period” means the relevant 40-day distribution compliance period as defined in Regulation S.
“Rule 144A” means Rule 144A under the Securities Act.

10

“Rule 144A Certificate” means (i) a certificate substantially in the form of Exhibit E hereto or (ii) a written certification addressed to the Company and the Trustee to the effect that the Person making such certification (x) is acquiring such Note (or beneficial interest) for its own account or one or more accounts with respect to which it exercises sole investment discretion and that it and each such account is a qualified institutional buyer within the meaning of Rule 144A, (y) is aware that the transfer to it or exchange, as applicable, is being made in reliance upon the exemption from the provisions of Section 5 of the Securities Act provided by Rule 144A, and (z) acknowledges that it has received such information regarding the Company as it has requested pursuant to Rule 144A(d)(4) or has determined not to request such information.
“S&P” means Standard & Poor’s Financial Services LLC, a division of S&P Global Inc., and its successors.
“Securities Act” means the Securities Act of 1933.
“Significant Subsidiary” means, at any particular time, any Subsidiary of the Company whose gross assets or gross revenues (having regard to the Company’s direct and/or indirect beneficial interest in the shares, or the like, of that Subsidiary) represent at least 25% of the consolidated gross assets or, as the case may be, consolidated gross revenues of the Company.
“Subsidiary” means, with respect to any person, any corporation, association, partnership, limited liability company or other business entity of which 50% or more of the total voting power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees is at the time owned, directly or indirectly, by (1) such person, (2) such person and one or more Subsidiaries of such person or (3) one or more Subsidiaries of such person.
“Surviving Person” has the meaning ascribed to such term in Section 5.01 hereof.
“Temporary Offshore Global Note” means an Offshore Global Note that bears the Temporary Offshore Global Note Legend.
“Temporary Offshore Global Note Legend” means the legend set forth in Exhibit G.
“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.
“Trustee” means the party named as such in the first paragraph of the Indenture or any successor trustee under the Indenture pursuant to Article 7.

11

“Trust Indenture Act” or “TIA” means the Trust Indenture Act of 1939, as amended.
“U.S. Global Note” means a Global Note that bears the Restricted Legend representing Notes issued and sold pursuant to Rule 144A.  “U.S. Government Obligation” means any:
(1)    security which is: (a) a direct obligation of the United States for the payment of which the full faith and credit of the United States is pledged or (b) an obligation of a person controlled or supervised by and acting as an agency or instrumentality of the United States the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States, which, in the case of clause (a) or (b), is not callable or redeemable at the option of the issuer of the obligation, and
(2)    depositary receipt issued by a bank (as defined in the Securities Act) as custodian with respect to any security specified in clause (1) above and held by such bank for the account of the holder of such depositary receipt or with respect to any specific payment of principal of or interest on any such security held by any such bank, provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligation or the specific payment of interest on or principal of the U.S. Government Obligation evidenced by such depositary receipt.
“Voting Stock” of any specified person means the capital stock of such person that is at the time entitled to vote generally in the election of the Board of Directors of such Person.

SECTION 1.02    Rules of Construction.  Unless the context otherwise requires or except as otherwise expressly provided,
(a)    an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP;
(b)    “herein,” “hereof” and other words of similar import refer to the Indenture as a whole and not to any particular Section, Article or other subdivision;
(c)    all references to Sections or Articles or Exhibits refer to Sections or Articles or Exhibits of or to the Indenture unless otherwise indicated;
(d)    references to agreements or instruments, or to statutes or regulations, are to such agreements or instruments, or statutes or regulations, as amended from time to time (or to successor statutes and regulations);
(e)    in the event that a transaction meets the criteria of more than one category of permitted transactions or listed exceptions the Company may classify such transaction as it, in its sole discretion, determines; and
(f)    all other terms used herein which are defined in the Trust Indenture Act, either directly or by reference therein, have the meaning assigned to them therein to the extent applicable.

ARTICLE 2 
THE NOTES

SECTION 2.01    Form, Dating and Denominations; Legends.  (a)  The Notes and the Trustee’s certificate of authentication related thereto will be substantially in the form attached as Exhibit A.  The terms and provisions contained in the form of Note annexed as Exhibit A constitute, and are hereby expressly made, a part of the Indenture.  The Notes may have notations, legends or endorsements required by law, rules of or agreements with national securities exchanges to which the Company is subject.  Each Note will be dated the date of its authentication.  The Notes will be issuable in minimum denominations of $2,000 in principal amount and integral multiples of $1,000 in excess thereof.
(b)    (i)    Except as otherwise provided in paragraph (c), Section 2.10(b)(iii) or (c), or Section 2.09(b)(iv), each Initial Note or Additional Note (other than a Permanent Offshore Note) will bear the Restricted Legend.

12

(ii)    Each Global Note, whether or not an Initial Note or Additional Note, will bear the DTC Legend.
(iii)    Each Temporary Offshore Global Note will bear the Temporary Offshore Global Note Legend.
(iv)    Initial Notes and Additional Notes offered and sold in reliance on Regulation S will be issued as provided in Section 2.11(a).
(c)    If the Company determines (upon the advice of counsel and such other certifications and evidence as the Company may reasonably require) that a Note is eligible for resale pursuant to Rule 144 under the Securities Act (or a successor rule) and that the Restricted Legend is no longer necessary or appropriate in order to ensure that subsequent transfers of the Note (or a beneficial interest therein) are effected in compliance with the Securities Act, the Company may instruct the Trustee to cancel the Note and issue to the Holder thereof (or to its transferee) a new Note of like tenor and amount, registered in the name of the Holder thereof (or its transferee), that does not bear the Restricted Legend, and the Trustee will comply with such instruction.
(d)    By its acceptance of any Note bearing the Restricted Legend (or any beneficial interest in such a Note), each Holder thereof and each owner of a beneficial interest therein acknowledges the restrictions on transfer of such Note (and any such beneficial interest) set forth in this Indenture and in the Restricted Legend and agrees that it will transfer such Note (and any such beneficial interest) only in accordance with the Indenture and such legend.

SECTION 2.02    Execution and Authentication; Additional Notes.  (a)  An Officer shall execute the Notes for the Company by facsimile or manual signature in the name and on behalf of the Company.  If an Officer whose signature is on a Note no longer holds that office at the time the Note is authenticated, the Note will still be valid.
(b)    A Note will not be valid until the Trustee manually signs the certificate of authentication on the Note, with the signature conclusive evidence that the Note has been authenticated under the Indenture.
(c)    At any time and from time to time after the execution and delivery of the Indenture, the Company may deliver Notes executed by the Company to the Trustee for authentication.  The Trustee will authenticate and deliver
(i)    Notes for original issue in the aggregate principal amount not to exceed $405,000,000, and
(ii)    Additional Notes from time to time for original issue in aggregate principal amounts specified by the Company

13

after the following conditions have been met:
(1)    Receipt by the Trustee of an Officers’ Certificate specifying
(A)    the amount of Notes to be authenticated and the date on which such Notes are to be authenticated,
(B)    whether such Notes are to be Initial Notes or Additional Notes,
(C)    in the case of Additional Notes, that the issuance of such Notes does not contravene any provision of Article 4 of the Indenture, and
(D)    other information the Company may determine to include or the Trustee may reasonably request (including, without limitation, statements per Section 10.04 herein).
(2)    In the case of Additional Notes, receipt by the Trustee of an Opinion of Counsel confirming that such Additional Notes are fungible with the Initial Notes for U.S. federal income tax purposes.  Additional Notes will be fungible with the Initial Notes if they are issued pursuant to a qualified reopening under Treasury Regulations section 1.1275-2(k) for U.S. federal income tax purposes.
(3)    An order of the Company to the Trustee to authenticate such Notes.
(4)    In the case of Additional Notes, an Opinion of Counsel per Section 10.04 herein.

SECTION 2.03    Registrar, Paying Agent and Authenticating Agent; Paying Agent to Hold Money in Trust.  (a)  The Company may appoint one or more Registrars and one or more Paying Agents, in which case each reference in the Indenture to the Trustee in respect of the obligations of the Trustee to be performed by that Agent will be deemed to be references to the Agent.  The Company may act as Registrar or (except for purposes of Article 8) Paying Agent.  In each case the Company and the Trustee will enter into an appropriate agreement with the Agent implementing the provisions of the Indenture relating to the obligations of the Trustee to be performed by the Agent and the related rights.  The Company initially appoints the Trustee as Registrar and Paying Agent.
(b)    The Company will require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust for the benefit of the Holders or the Trustee all money held by the Paying Agent for the payment of principal of and interest on the Notes and will promptly notify the Trustee of any default by the Company in making any such payment.  The Company at any time may require a Paying Agent to pay all money held by it to 

14

the Trustee and account for any funds disbursed, and the Trustee may at any time during the continuance of any payment default, upon written request to a Paying Agent, require the Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed.  Upon doing so, the Paying Agent will have no further liability for the money so paid over to the Trustee.

SECTION 2.04    Replacement Notes.  If a mutilated Note is surrendered to the Trustee or if a Holder claims that its Note has been lost, destroyed or wrongfully taken, the Company will issue and the Trustee will authenticate a replacement Note of like tenor and principal amount and bearing a number not contemporaneously outstanding.  Every replacement Note is an additional obligation of the Company and entitled to the benefits of the Indenture.  If required by the Trustee or the Company, an indemnity must be furnished that is sufficient in the judgment of both the Trustee and the Company to protect the Company and the Trustee from any loss they may suffer if a Note is replaced.  The Company may charge the Holder for the expenses of the Company and the Trustee in replacing a Note.  In case the mutilated, lost, destroyed or wrongfully taken Note has become or is about to become due and payable, the Company in its discretion may pay the Note instead of issuing a replacement Note.

SECTION 2.05    Outstanding Notes.  (a)  Notes outstanding at any time are all Notes that have been authenticated by the Trustee except for:
(i)    Notes cancelled by the Trustee or delivered to it for cancellation;
(ii)    any Note which has been replaced pursuant to Section 2.04 unless and until the Trustee and the Company receive proof satisfactory to them that the replaced Note is held by a bona fide purchaser; and
(iii)    on or after the maturity date or any redemption date or date for purchase of the Notes pursuant to a Change of Control Offer, those Notes payable or to be redeemed or purchased on that date for which the Trustee (or Paying Agent, other than the Company or an Affiliate of the Company) holds money sufficient to pay all amounts then due.
(b)    A Note does not cease to be outstanding because the Company or one of its Affiliates holds the Note, provided that in determining whether the Holders of the requisite principal amount of the outstanding Notes have given or taken any request, demand, authorization, direction, notice, consent, waiver or other action hereunder, Notes owned by the Company or any Affiliate of the Company will be disregarded and deemed not to be outstanding (it being understood that in determining whether the Trustee is protected in relying upon any such request, demand, authorization, direction, notice, consent, waiver or other action, only Notes which a Responsible Officer of the Trustee actually knows to be so owned will be so disregarded).  Notes so owned which have been pledged in good faith may be regarded as outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to 

15

act with respect to such Notes and that the pledgee is not the Company or any Affiliate of the Company.

SECTION 2.06    Temporary Notes.  Until definitive Notes are ready for delivery, the Company may prepare and the Trustee will authenticate temporary Notes.  Temporary Notes will be substantially in the form of definitive Notes but may have insertions, substitutions, omissions and other variations determined to be appropriate by the Officer executing the temporary Notes, as evidenced by the execution of the temporary Notes.  If temporary Notes are issued, the Company will cause definitive Notes to be prepared without unreasonable delay.  After the preparation of definitive Notes, the temporary Notes will be exchangeable for definitive Notes upon surrender of the temporary Notes at the office or agency of the Company designated for the purpose pursuant to Section 4.02, without charge to the Holder.  Upon surrender for cancellation of any temporary Notes, the Company will execute and the Trustee will authenticate and deliver in exchange therefor a like principal amount of definitive Notes of authorized denominations.  Until so exchanged, the temporary Notes will be entitled to the same benefits under the Indenture as definitive Notes.

SECTION 2.07    Cancellation.  The Company at any time may deliver to the Trustee for cancellation any Notes previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and may deliver to the Trustee for cancellation any Notes previously authenticated hereunder which the Company has not issued and sold.  Any Registrar or the Paying Agent will forward to the Trustee any Notes surrendered to it for transfer, exchange or payment.  The Trustee will cancel all Notes surrendered for transfer, exchange, payment or cancellation and dispose of them in accordance with its normal procedures or the written instructions of the Company.  The Company may not issue new Notes to replace Notes it has paid in full or delivered to the Trustee for cancellation.

SECTION 2.08    CUSIP and CINS Numbers.  The Company in issuing the Notes may use “CUSIP” and “CINS” numbers for the Notes, and the Trustee will use CUSIP numbers or CINS numbers in notices of redemption and in Change of Control Offers as a convenience to Holders, the notice to state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of redemption or Change of Control Offer.  The Company will promptly notify the Trustee of any change in the CUSIP or CINS numbers.

SECTION 2.09    Registration, Transfer and Exchange.  (a)  The Notes will be issued in registered form only, without coupons, and except under the circumstances described in subsections (b)(ii) or (b)(iv) of this Section 2.09, the Notes will be issued in global form only.  The Company shall cause the Trustee to maintain a register (the “Register”) of the Notes, for registering the record ownership of Notes by the Holders thereof and transfers and exchanges of the Notes.

16

(b)    (i)    Each Global Note will be registered in the name of the Depositary or its nominee and, so long as DTC is serving as the Depositary thereof, will bear the DTC Legend.
(ii)    Each Global Note will be delivered to the Trustee as custodian for the Depositary.  Transfers of a Global Note (but not a beneficial interest therein) will be limited to transfers thereof in whole, but not in part, to the Depositary, its successors or their respective nominees, except (x) as set forth in Section 2.09(b)(iv) and (y) transfers of portions thereof in the form of Certificated Notes may be made upon request of an Agent Member (for itself or on behalf of a beneficial owner) by written notice given to the Trustee by or on behalf of the Depositary in accordance with customary procedures of the Depositary and in compliance with this Section and Section 2.10.
(iii)    Agent Members will have no rights under the Indenture with respect to any Global Note held on their behalf by the Depositary, and the Depositary may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Note for all purposes whatsoever.  Notwithstanding the foregoing, the Depositary or its nominee may grant proxies and otherwise authorize any Person (including any Agent Member and any Person that holds a beneficial interest in a Global Note through an Agent Member) to take any action which a Holder is entitled to take under the Indenture or the Notes, and nothing herein will impair, as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of a holder of any security.
(iv)    If (A) the Depositary (x) notifies the Company that it is unwilling or unable to continue as Depositary for a Global Note or (y) has ceased to be a clearing agency registered under the Exchange Act, and in each case a successor depositary is not appointed by the Company within 90 days of that notice or becoming aware that the Depositary is no longer so registered or willing or able to act as a depositary, (B) the Company determines not to have the Notes represented by a Global Note and provides written notice thereof to the Trustee; provided that in no event shall a Temporary Offshore Global Note be exchanged for certificated Notes prior to the expiration of the distribution compliance period and the receipt of any required Regulation S Certificate; or (C) an Event of Default shall have occurred and be continuing with respect to the Notes, the Trustee will promptly exchange each beneficial interest in each Global Note for one or more Certificated Notes in authorized denominations having an equal aggregate principal amount registered in the name of the owner of such beneficial interest, as identified to the Trustee by the Depositary, and thereupon each Global Note will be deemed canceled.  If a Global Note does not bear the Restricted Legend, then the Certificated Notes issued in exchange therefor will not bear the Restricted Legend.  If a Global Note bears the Restricted Legend, then the Certificated Notes issued in exchange therefor will bear the Restricted Legend, provided that any Holder of any such 

17

Certificated Note issued in exchange for a beneficial interest in a Temporary Offshore Global Note will have the right upon presentation to the Trustee of a duly completed Certificate of Beneficial Ownership after the Restricted Period to exchange such Certificated Note for a Certificated Note of like tenor and amount that does not bear the Restricted Legend, registered in the name of such Holder.
(c)    Each Certificated Note issued pursuant to subsection (b)(iv) will be registered in the name of the Holder thereof or its nominee.
(d)    A Holder may transfer a Note (or a beneficial interest therein) to another Person or exchange a Note (or a beneficial interest therein) for another Note or Notes of any authorized denomination by presenting to the Trustee a written request therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other document required by Section 2.10.  The Trustee will promptly register any transfer or exchange that meets the requirements of this Section by noting the same in the register maintained by the Trustee for the purpose; provided that:
(i)    no transfer or exchange will be effective until it is registered in such register and
(ii)    the Trustee will not be required (x) to issue, register the transfer of or exchange any Note for a period of 15 days before a selection of Notes to be redeemed or purchased pursuant to a Change of Control Offer, (y) to register the transfer of or exchange any Note so selected for redemption or purchase in whole or in part, except, in the case of a partial redemption or purchase, that portion of any Note not being redeemed or purchased, or (z) if a redemption or a purchase pursuant to a Change of Control Offer is to occur after a Regular Record Date but on or before the corresponding Interest Payment Date, to register the transfer of or exchange any Note on or after the Regular Record Date and before the date of redemption or purchase.  Prior to the registration of any transfer, the Company, the Trustee and their agents will treat the Person in whose name any Note is registered as the owner and Holder thereof for all purposes (whether or not the Note is overdue), and will not be affected by notice to the contrary.
From time to time the Company will execute and the Trustee will authenticate additional Notes as necessary in order to permit the registration of a transfer or exchange in accordance with this Section.
No service charge will be imposed in connection with any transfer or exchange of any Note, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than a transfer tax or other similar governmental charge payable upon exchange pursuant to subsection (b)(iv)).

18

(e)    (i)    Global Note to Global Note.  If a beneficial interest in a Global Note is transferred or exchanged for a beneficial interest in another Global Note, the Trustee will (x) record a decrease in the principal amount of the Global Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the principal amount of the other Global Note.  Any beneficial interest in one Global Note that is transferred to a Person who takes delivery in the form of an interest in another Global Note, or exchanged for an interest in another Global Note, will, upon transfer or exchange, cease to be an interest in such Global Note and become an interest in the other Global Note and, accordingly, will thereafter be subject to all transfer and exchange restrictions, if any, and other procedures applicable to beneficial interests in such other Global Note for as long as it remains such an interest.
(ii)    Certificated Note to Certificated Note.  If a Certificated Note is transferred or exchanged for another Certificated Note, the Trustee will (x) cancel the Certificated Note being transferred or exchanged, (y) deliver one or more new Certificated Notes in authorized denominations having an aggregate principal amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the canceled Certificated Note (in the case of an exchange), registered in the name of such transferee or Holder, as applicable, and (z) if such transfer or exchange involves less than the entire principal amount of the canceled Certificated Note, deliver to the Holder thereof one or more Certificated Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Certificated Note, registered in the name of the Holder thereof.

SECTION 2.10    Restrictions on Transfer and Exchange.  (a)  The transfer or exchange of any Note (or a beneficial interest therein) may only be made in accordance with this Section and Section 2.09 and, in the case of a Global Note (or a beneficial interest therein), the applicable rules and procedures of the Depositary.  The Trustee shall refuse to register any requested transfer or exchange that does not comply with the preceding sentence.
(b)    Subject to paragraph (c), the transfer or exchange of any Note (or a beneficial interest therein) of the type set forth in column A below for a Note (or a beneficial interest therein) of the type set forth opposite in column B below may only be made in compliance with the certification requirements (if any) described in the clause of this paragraph set forth opposite in column C below.

19

	
			
	A
	B
	C

	U.S. Global Note
	U.S. Global Note
	(i)

	U.S. Global Note
	Offshore Global Note
	(ii)

	Certificated Note
	Certificated Note
	(iii)

	Offshore Global Note
	U.S. Global Note
	(iv)

	Offshore Global Note
	Offshore Global Note
	(i)

	 
	 
	 

(i)    No certification is required.
(ii)    The Person requesting the transfer or exchange must deliver or cause to be delivered to the Trustee a duly completed Regulation S Certificate.
(iii)    The Person requesting the transfer or exchange must deliver or cause to be delivered to the Trustee (x) a duly completed Rule 144A Certificate or (y) a duly completed Regulation S Certificate, and/or an Opinion of Counsel and such other certifications and evidence as the Company may reasonably require in order to determine that the proposed transfer or exchange is being made in compliance with the Securities Act and any applicable securities laws of any state of the United States; provided that if the requested transfer or exchange is made by the Holder of a Certificated Note that does not bear the Restricted Legend, then no certification is required.  In the event that (1) the requested transfer or exchange takes place after the Restricted Period and a duly completed Regulation S Certificate is delivered to the Trustee or (2) a Certificated Note that does not bear the Restricted Legend is surrendered for transfer or exchange, upon transfer or exchange the Trustee will deliver a Certificated Note that does not bear the Restricted Legend.
(iv)    The Person requesting the transfer or exchange must deliver or cause to be delivered to the Trustee a duly completed Rule 144A Certificate.
(c)    No certification is required in connection with any transfer or exchange of any Note (or a beneficial interest therein) after such Note (i) is eligible for resale pursuant to Rule 144 under the Securities Act (or a successor provision); provided that the Company has provided the Trustee with an Officer’s Certificate to that effect, and the Company may require from any Person requesting a transfer or exchange in reliance upon this clause an opinion of counsel and any other reasonable certifications and evidence in order to support such certificate; or (ii) sold pursuant to an effective registration statement.
Any Certificated Note delivered in reliance upon this paragraph will not bear the Restricted Legend.
(d)    The Trustee will retain copies of all certificates, opinions and other documents received in connection with the transfer or exchange of a Note (or a beneficial 

20

interest therein), and the Company will have the right to inspect and make copies thereof at any reasonable time upon reasonable prior written notice to the Trustee.

SECTION 2.11    Temporary Offshore Global Notes.  (a)  Each Note originally sold by the Initial Purchasers in reliance upon Regulation S will be evidenced by one or more Offshore Global Notes that bear the Temporary Offshore Global Note Legend.
(b)    An owner of a beneficial interest in a Temporary Offshore Global Note (or a Person acting on behalf of such an owner) may provide to the Trustee (and the Trustee will accept) a duly completed Certificate of Beneficial Ownership at any time after the Restricted Period (it being understood that the Trustee will not accept any such certificate during the Restricted Period).  Promptly after acceptance of a Certificate of Beneficial Ownership with respect to such a beneficial interest, the Trustee will cause such beneficial interest to be exchanged for an equivalent beneficial interest in a Permanent Offshore Global Note, and will (x) permanently reduce the principal amount of such Temporary Offshore Global Note by the amount of such beneficial interest and (y) increase the principal amount of such Permanent Offshore Global Note by the amount of such beneficial interest.
(c)    Notwithstanding anything to the contrary contained herein, beneficial interests in a Temporary Offshore Global Note may be held through the Depositary only through Euroclear and Clearstream and their respective direct and indirect participants.
(d)    Notwithstanding paragraph (b), if after the Restricted Period any Initial Purchaser owns a beneficial interest in a Temporary Offshore Global Note, such Initial Purchaser may, upon written request to the Trustee accompanied by a certification as to its status as an Initial Purchaser, exchange such beneficial interest for an equivalent beneficial interest in a Permanent Offshore Global Note, and the Trustee will comply with such request and will (x) permanently reduce the principal amount of such Temporary Offshore Global Note by the amount of such beneficial interest and (y) increase the principal amount of such Permanent Offshore Global Note by the amount of such beneficial interest.

ARTICLE 3 
OPTIONAL REDEMPTION

SECTION 3.01    Optional Redemption.  (a)  The Notes are subject to redemption upon not less than 30 nor more than 60 days’ notice mailed to each holder of Notes to be redeemed at its address appearing in the Register, prior to July 1, 2024, at any time in whole or in part, at the election of the Company at a price (the “Redemption Price”) equal to the greater of:
(i)    100% of the principal amount of the Notes being redeemed; or
(ii)    the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed that would be due if such notes matured on the Par Call Date (excluding interest accrued to the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year 

21

consisting of twelve 30-day months) at a discount rate equal to the Treasury Rate plus 30 basis points;
plus, for (i) or (ii) above, whichever is applicable, accrued interest on such Notes to, but not including, the date of redemption.
(b)    Under the procedures set forth above, the Redemption Price payable upon the optional redemption prior to July 1, 2024 of any Notes called for redemption shall be determined by calculating the present value at that time of each remaining payment of principal of or interest on such Notes and then totaling those present values.  If the sum of those present values is equal to or less than 100% of the principal amount of the Notes called for redemption, the Redemption Price of such Notes shall be 100% of its principal amount (redemption at par).  If the sum of the present values is greater than 100% of the principal amount of the Notes called for redemption, the Redemption Price of such Notes shall be that greater amount (redemption at a premium).  In no event may any Notes be redeemed optionally at less than 100% of their principal amount.  The Redemption Price will be calculated by the Quotation Agent and the Company, the Trustee and any Paying Agent will be entitled to rely on such calculation.
(c)    At any time on or after July 1, 2024, the Notes will be redeemable in whole or in part, at the election of the Company, at a Redemption Price equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest on the Notes to be redeemed to, but not including, the date of redemption

SECTION 3.02    Method and Effect of Redemption.  (a)  If the Company elects to redeem any Notes, it must notify the Trustee of the redemption date and the principal amount of Notes to be redeemed by delivering an Officers’ Certificate to the Trustee at least 15 days prior to the date of the mailing of the notice (unless a shorter period is satisfactory to the Trustee in the sole determination of the Trustee).  If fewer than all of the Notes are being redeemed, the Officers’ Certificate must also specify a record date not less than 15 days after the date of the notice of redemption is given to the Trustee, and the Trustee will select the Notes to be redeemed pro rata, by lot or by any other method the Trustee in its sole discretion deems appropriate, in denominations of $1,000 principal amount and multiples thereof, provided that no Notes of $2,000 or less will be redeemed in part.  The Trustee will notify the Company promptly of the Notes or portions of Notes to be called for redemption.  Notice of redemption must be sent by the Company or at the Company’s request (the Company to provide or cause to be provided to the Trustee such information to be included in such notice five (5) days prior to such notice being sent to Holders, unless a shorter period is satisfactory to the Trustee, in the sole determination of the Trustee), by the Trustee in the name and at the expense of the Company, to Holders whose Notes are to be redeemed at least 30 days but not more than 60 days before the redemption date.
(b)    The notice of redemption will identify the Notes to be redeemed and will include or state the following:

22

(i)    the redemption date;
(ii)    the Redemption Price, including the portion thereof representing any accrued interest;
(iii)    the place or places where Notes are to be surrendered for redemption;
(iv)    Notes called for redemption must be so surrendered in order to collect the Redemption Price;
(v)    on the redemption date the Redemption Price will become due and payable on Notes called for redemption, and interest on Notes called for redemption will cease to accrue on and after the redemption date;
(vi)    if any Note is redeemed in part, on and after the redemption date, upon surrender of such Note, new Notes equal in principal amount to the unredeemed portion will be issued; and
(vii)    if any Note contains a CUSIP or CINS number, no representation is being made as to the correctness of the CUSIP or CINS number either as printed on the Notes or as contained in the notice of redemption and that the Holder should rely only on the other identification numbers printed on the Notes.
(c)    Once notice of redemption is sent to the Holders, Notes called for redemption become due and payable at the Redemption Price on the redemption date, and upon surrender of the Notes called for redemption, the Company shall redeem such Notes at the Redemption Price.  Commencing on the redemption date, Notes redeemed will cease to accrue interest.  Upon surrender of any Note redeemed in part, the Holder will receive a new Note equal in principal amount to the unredeemed portion of the surrendered Note.

SECTION 3.03    Sinking Fund.  No sinking fund is provided for the Notes.

ARTICLE 4 
COVENANTS

SECTION 4.01    Payment of Notes.  (a)  The Company agrees to pay the principal of, premium, if any, and interest on the Notes on the dates and in the manner provided in the Notes and the Indenture.  Not later than 9:00 A.M. (New York City time) on the due date of any principal of, premium, if any, or interest on any Notes, or any redemption or purchase price of the Notes, the Company will deposit with the Trustee (or Paying Agent) money in immediately available funds sufficient to pay such amounts, provided that if the Company or any Affiliate of the Company is acting as Paying Agent, it will, on or before each due date, segregate and hold in a separate trust fund for the benefit of the Holders a sum of money sufficient to pay 

23

such amounts until paid to such Holders or otherwise disposed of as provided in the Indenture.  In each case the Company will promptly notify the Trustee of its compliance with this paragraph.
(b)    An installment of principal or interest will be considered paid on the date due if the Trustee (or Paying Agent, other than the Company or any Affiliate of the Company) holds on that date money designated for and sufficient to pay the installment.  If the Company or any Affiliate of the Company acts as Paying Agent, an installment of principal or interest will be considered paid on the due date only if paid to the Holders.
(c)    The Company agrees to pay interest on overdue principal, and, to the extent lawful, overdue installments of interest at the rate per annum specified in the Notes.
(d)    Payments in respect of the Notes represented by the Global Notes are to be made by electronic funds transfer of immediately available funds to the accounts specified by the Holders of the Global Notes.  With respect to Certificated Notes, the Company will make all payments by electronic funds transfer of immediately available funds to the accounts specified by the Holders thereof or, if no such account is specified, by mailing a check to each Holder’s registered address.

SECTION 4.02    Maintenance of Office or Agency.  The Company will maintain in the Borough of Manhattan, the City of New York, an office or agency where Notes may be surrendered for registration of transfer or exchange or for presentation for payment and where notices and demands to or upon the Company in respect of the Notes and the Indenture may be served.  The Company hereby initially designates the office of the Trustee located at 100 Wall Street, 16th Floor, New York, NY 10005, as one such office of the Company.  The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency.  If at any time the Company fails to maintain any such required office or agency or fails to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served to the Trustee.
The Company may also from time to time designate one or more other offices or agencies where the Notes may be surrendered or presented for any of such purposes and may from time to time rescind such designations.  The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency.

SECTION 4.03    Limitations on Liens.  (a)  Liens on the IPL Stock.  The Company may not secure any Indebtedness of any Person, other than IPALCO Indebtedness, by a Lien upon any common stock of IPL.
(b)    Liens on Property or Assets other than the IPL Stock.  Neither the Company nor any Significant Subsidiary shall issue, assume or guarantee any Indebtedness secured by a Lien upon any property or assets (other than any capital stock of IPL or cash or cash 

24

equivalents) of the Company or such Significant Subsidiary, as applicable, without effectively providing that the outstanding Notes (together with, if the Company so determines, any other Indebtedness or obligation then existing or thereafter created ranking equally with the Notes) will be secured equally and ratably with (or prior to) such Indebtedness so long as such Indebtedness is so secured.  The foregoing limitation on Liens of this clause (b) will not, however, apply to:
(i)    Liens in existence on the Issue Date;
(ii)    any Lien created or arising over any property which is acquired, constructed or created by the Company or any of its Significant Subsidiaries, but only if:
(A)    such Lien secures only principal amounts (not exceeding the cost of such acquisition, construction or creation) raised for the purposes of such acquisition, construction or creation, together with any costs, expenses, interest and fees Incurred in relation to that property or a guarantee given in respect of that property;
(B)    such Lien is created or arises on or before 180 days after the completion of such acquisition, construction or creation; and
(C)    such Lien is confined solely to the property so acquired, constructed or created;
(iii)    (A)    rights of financial institutions to offset credit balances in connection with the operation of cash management programs established for the benefit of the Company and/or a Significant Subsidiary or in connection with the issuance of letters of credit for the benefit of the Company and/or a Significant Subsidiary;
(B)    any Lien on accounts receivable securing Indebtedness of the Company and/or a Significant Subsidiary Incurred in connection with the financing of such accounts receivable;
(C)    any Lien Incurred or deposits made in the ordinary course of business, including, but not limited to, (x) any mechanic’s, materialmen’s, carrier’s, workmen’s, vendors’ and other like Liens and (y) any Liens securing amounts in connection with workers’ compensation, unemployment insurance and other types of social security;
(D)    any Lien upon specific items of inventory or other goods of the Company and/or a Significant Subsidiary and the proceeds thereof securing obligations of the Company and/or a Significant Subsidiary in respect of bankers’ 

25

acceptances issued or created for the account of such person to facilitate the purchase, shipment or storage of such inventory or other goods;
(E)    any Lien Incurred or deposits made securing the performance of tenders, bids, leases, trade contracts (other than for borrowed money), statutory obligations, surety bonds, appeal bonds, government contracts, performance bonds, return-of-money bonds, letters of credit not securing borrowings and other obligations of like nature Incurred in the ordinary course of business;
(F)    any Lien created by the Company or a Significant Subsidiary under or in connection with or arising out of a Currency, Interest Rate or Commodity Agreement or any transactions or arrangements entered into in connection with the hedging or management of risks relating to the electricity or natural gas distribution industry, including a right of set off or right over a margin call account or any form of cash or cash collateral or any similar arrangement for obligations Incurred in respect of Currency, Interest Rate or Commodity Agreements;
(G)    any Lien arising out of title retention or like provisions in connection with the purchase of goods and equipment in the ordinary course of business; and
(H)    any Lien securing reimbursement obligations under letters of credit, guaranties and other forms of credit enhancement given in connection with the purchase of goods and equipment in the ordinary course of business;
(iv)    Liens in favor of the Company or a Subsidiary of the Company;
(v)    (A)    Liens on any property or assets acquired from an entity which is merged with or into the Company or a Significant Subsidiary or any Liens on the property or assets of any entity existing at the time such entity becomes a Subsidiary of the Company and, in either case, is not created in anticipation of the transaction, unless the Lien was created to secure or provide for the payment of any part of the purchase price of that entity;
(B)    any Lien on any property or assets existing at the time of its acquisition and which is not created in anticipation of such acquisition, unless the Lien was created to secure or provide for the payment of any part of the purchase price of such property or assets; and
(C)    any Lien created or outstanding on or over any asset of any entity which becomes a Significant Subsidiary on or after the date of the issuance 

26

of the notes, where the Lien is created prior to the date on which that entity becomes a Significant Subsidiary;
(vi)    (A)    Liens required by any contract, statute or regulation in order to permit the Company or a Significant Subsidiary to perform any contract or subcontract made by it with or at the request of a governmental entity or any governmental department, agency or instrumentality, or to secure partial, progress, advance or any other payments by the Company or a Significant Subsidiary to such governmental unit under the provisions of any contract, statute or regulation;
(B)    any Lien securing industrial revenue, development, pollution control, solid waste disposal or similar bonds issued by or for the benefit of the Company or a Significant Subsidiary, provided that such industrial revenue, development, pollution control or similar bonds do not provide recourse generally to the Company and/or such Significant Subsidiary; and
(C)    any Lien securing taxes or assessments or other applicable governmental charges or levies;
(vii)    any Lien which arises under any order of attachment, restraint or similar legal process arising in connection with court proceedings and any Lien which secures the reimbursement obligation for any bond obtained in connection with an appeal taken in any court proceeding, so long as the execution or other enforcement of such Lien arising under such legal process is effectively stayed and the claims secured by that Lien are being contested in good faith and, if appropriate, by appropriate legal proceedings, and any Lien in favor of a plaintiff or defendant in any action before a court or tribunal as security for costs and/or expenses;
(viii)    any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of any Liens referred to in the foregoing clauses, for amounts not exceeding the principal amount of the Indebtedness secured by the Lien so extended, renewed or replaced, provided that such extension, renewal or replacement Lien is limited to all or a part of the same property or assets that were covered by the Lien extended, renewed or replaced (plus improvements on such property or assets);
(ix)    any Lien created in connection with Project Finance Debt;
(x)    any Lien created by IPL or its subsidiaries securing Indebtedness of IPL or its subsidiaries;
(xi)    any Lien created in connection with the securitization of some or all of the assets of IPL and the associated issuance of Indebtedness as authorized by 

27

applicable state or federal law in connection with the restructuring of jurisdictional electric or gas businesses; and
(xii)    any Lien on stock created in connection with a mandatorily convertible or exchangeable stock or debt financing, provided that any such financing may not be secured by or otherwise involve the creation of a Lien on any capital stock of IPL or any successor entity to IPL.

SECTION 4.04    Noteholders’ Lists.  The Company will furnish or cause to be furnished to the Trustee a list in such form as the Trustee may reasonably require of the names and addresses of the holders of the Notes pursuant to Section 312 of the Trust Indenture Act (a) semi-annually not more than 15 days after each record date for the payment of semi-annual interest on the Notes, as hereinabove specified, as of such record date, and (b) at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request as of a date not more than 15 days prior to the time such information is furnished.

SECTION 4.05    Certificate to Trustee.  The Company will furnish to the Trustee annually, on or before a date not more than four months after the end of its fiscal year (which, on the date hereof, is a calendar year), a brief certificate (which need not contain the statements required by Section 10.04) from its principal executive, financial or accounting officer as to his or her knowledge of the compliance of the Company with all conditions and covenants under this Indenture (such compliance to be determined without regard to any period of grace or requirement of notice provided under this Indenture) which certificate shall comply with the requirements of the Trust Indenture Act.  The Company shall also notify the Trustee of any Default or Event of Default under this Indenture, provided, however, that a failure by the Company to deliver such notice shall not constitute a Default or an Event of Default under this Indenture, if the Company has remedied such Default within any applicable grace period.

SECTION 4.06    Reports by the Company.  (a)  So long as the Company is required to be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company shall provide copies to the Trustee with the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may by rules and regulations prescribe) that the Company is required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act.  Notwithstanding that the Company may not be required to be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, or does not otherwise report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to the rules and regulations promulgated by the Commission, the Company shall make available to the Trustee and to the Holders, without cost to any Holder:
(i)    within 90 days after the end of each fiscal year, audited financial statements; and

28

(ii)    within 45 days after the end of the first three fiscal quarters of each fiscal year (commencing no earlier than the fiscal quarter ending September 30, 2017), quarterly unaudited financial statements.
(b)    If the Company ceases to be subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act, the Company will provide, without charge, upon the written request of (x) a Holder of any Notes or (y) a prospective Holder of any of the Notes who is a “qualified institutional buyer” within the meaning of Rule 144A and is designated by an existing Holder of any of the Notes (in each case, with a copy to the Trustee), with the information with respect to the Company required to be delivered under Rule 144A(d)(4) under the Securities Act to enable resales of the Notes to be made pursuant to Rule 144A.  Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusive on Officers’ Certificates).

SECTION 4.07    Repurchase of Notes Upon a Change of Control.  (a)  Upon the occurrence of a Change of Control Triggering Event, each holder of the Notes shall have the right to require that the Company repurchase all or any part (no note of a principal amount of $2,000 or less will be repurchased in part) of such holder’s Notes (the “Change of Control Offer”) at a repurchase price in cash equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the date of repurchase (the “Change of Control Payment”).
(b)    Within 30 days following any Change of Control, the Company shall mail a notice to each Holder of the Notes with a copy to the Trustee stating:
(i)    that a Change of Control has occurred and that such Holder has the right to require the Company to repurchase such Holder’s Notes at a repurchase price in cash equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the date of repurchase;
(ii)    the transaction or transactions that constitute the Change of Control Triggering Event; and
(iii)    the repurchase date (which shall be not earlier than 30 days or later than 60 days from the date such notice is mailed).
(c)    The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connect with the repurchase of Notes as a result of a Change of Control Triggering Event.  To the extent that the provisions of any securities laws or regulations 

29

conflict with the Change of Control provisions of the Notes, the Company shall comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control provisions of the Notes by virtue of such conflicts.
(d)    On the Change of Control Date, the Company shall (i) accept for payment all Notes or portions of Notes properly tendered pursuant to the Change of Control Offer; (ii) deposit with the paying agent, which shall initially be the Trustee, an amount equal to the Change of Control Payment in respect of all Notes or portions of Notes properly tendered and (iii) deliver or cause to be delivered to the Trustee the Notes properly accepted.

ARTICLE 5 
CONSOLIDATION, MERGER OR SALE OF ASSETS

SECTION 5.01    Limitations on Merger, Consolidation, Sale, Lease or Conveyance.  The Company shall not (i)(a) consolidate with or merge with or into any other Person, or permit any Person to merge into or consolidate with the Company, or convey, transfer or lease its consolidated properties and assets substantially as an entirety (in one transaction or in a series of related transactions), (b) convey, transfer or lease its consolidated electric transmission and distribution assets and operations substantially as an entirety (in one transaction or in a series of related transactions), or (c) convey, transfer or lease all or substantially all of its consolidated electric generation assets and operations (in one transaction or a series of transactions), to any Person or  (ii) permit any of its Subsidiaries to enter into any such transaction or series of transactions if it would result in the disposition of (x) the Company’s consolidated properties and assets substantially as an entirety, (y) the Company’s consolidated electric transmission and distribution assets and operations substantially as an entirety or (z) all or substantially all of the Company’s consolidated electric generation assets and operations unless, in each case:
(A)    either (1) the Company will be the surviving entity, or (2) the surviving entity, if other than the Company, formed by such consolidation or into which the Company is merged or that acquired or leased such property or assets (the “Surviving Person”) shall be an entity organized under the laws of the United States of America, one of its States or the District of Columbia and expressly assumes by supplemental indenture the Company’s obligations under the Notes and the Indenture, provided, however, that in the event following a conveyance, transfer or lease of the Company’s consolidated properties and assets substantially as an entirety or a conveyance, transfer or lease of all or substantially all of the Company’s consolidated electric generation assets and operations, the Company continues to own, directly or indirectly, its consolidated electric transmission and distribution assets and operations that it held immediately preceding such conveyance, transfer or lease substantially as an entirety, the 

30

Notes and the Indenture shall remain the obligations of the Company and shall not be assumed by the Surviving Person;
(B)    immediately after giving effect to that transaction, no Event of Default shall have occurred and be continuing; and
(C)    the Company shall have delivered to the Trustee an Opinion of Counsel and Officer’s Certificate stating that such merger, consolidation, sale, lease or conveyance and such supplemental indenture (if any) complies with this Section 5.01 and that all conditions precedent provided for herein relating to such transaction have been complied with and that such supplemental indenture (if any) constitutes the legal, valid and binding obligation of the Surviving Person enforceable against such entity in accordance with its terms, subject to customary exceptions.

SECTION 5.02    Successor Substituted.  Except as otherwise provided in the proviso to Section 5.01(ii)(A), upon any consolidation or merger, or any sale, conveyance, transfer, lease or other disposition of all or substantially all of the property and assets of the Company in accordance with Section 5.01 of this Indenture, the Surviving Person formed by such consolidation or into which the Company is merged or to which such sale, conveyance, transfer, lease or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such Surviving Person had been named as the Company herein.

ARTICLE 6
DEFAULT AND REMEDIES

SECTION 6.01    Events of Default.  An “Event of Default” occurs with respect to the Notes if:
(i)    the Company defaults in the payment of the principal of, or any premium on, any Note when the same becomes due and payable at maturity, upon acceleration, redemption or required purchase or otherwise;
(ii)    the Company defaults in the payment of interest on any Note when the same becomes due and payable, and the default continues for a period of 30 days;
(iii)    the Company defaults in the performance of or breaches any other covenant or agreement of the Company in the Indenture or under the Notes and the default or breach continues for a period of 30 consecutive days after written notice specifying the default is delivered to the Company by the Trustee or to the Company and the Trustee by the Holders of 25% or more in aggregate principal amount of the Notes;

31

(iv)    a default occurs in the payment of the principal of any bond, debenture, note or other evidence of indebtedness, in each case for money borrowed, issued by the Company, or in the payment of principal under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for Borrowed Money, of the Company or any Significant Subsidiary if such Indebtedness for Borrowed Money is not Project Finance Debt and provides for recourse generally to the Company or any Significant Subsidiary, which default for payment of principal is in an aggregate principal amount exceeding $40.0 million when such indebtedness becomes due and payable (whether at maturity, upon redemption or acceleration or otherwise), if such default shall continue unremedied or unwaived for more than 30 Business Days and the time for payment of such amount has not been expressly extended (until such time as such payment default is remedied, cured or waived);
(v)    a court having jurisdiction enters a decree or order for: (i) relief in respect of the Company or any of its Significant Subsidiaries in an involuntary case under any applicable bankruptcy, insolvency, or other similar law now or hereafter in effect; (ii) appointment of a receiver, liquidator, assignee, custodian, trustee, sequestrator, or similar official of the Company or any of its Significant Subsidiaries or for all or substantially all of the property and assets of the Company or any of its Significant Subsidiaries; or (iii) the winding up or liquidation of the affairs of the Company or any of its Significant Subsidiaries; and, in each case, such decree or order shall remain unstayed and in effect for a period of 60 consecutive days;
(vi)    the Company or any of its Significant Subsidiaries: (i) commences a voluntary case under any applicable bankruptcy, insolvency, or other similar law now or hereafter in effect, or consents to the entry of an order for relief in an involuntary case under any such law; (ii) consents to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator, or similar official of the Company or any of its Significant Subsidiaries or for all or substantially all of the property and assets of the Company or any of its Significant Subsidiaries; or (iii) effects any general assignment for the benefit of creditors (an event of default specified in clause (v) or (vi) a “Bankruptcy Default”); or
(vii)    the Collateral Agent fails to have a perfected security interest in the Pledged Stock of IPL for a period of 10 days.

SECTION 6.02    Acceleration.  (a)  If an Event of Default, other than a Bankruptcy Default with respect to the Company, occurs with respect to the Notes and is continuing under the Indenture, the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding, by written notice to the Company (and to the Trustee if the notice is given by the Holders), may, and the Trustee at the request of such Holders shall, declare 

32

the principal of, premium, if any, and accrued interest on the outstanding Notes to be immediately due and payable.  Upon a declaration of acceleration, such principal, premium, if any, and accrued interest will become immediately due and payable.  If a Bankruptcy Default occurs with respect to the Company, the principal of, premium, if any, and accrued interest on the Notes then outstanding will become immediately due and payable without any declaration or other act on the part of the Trustee or any Holder.
(a)    The Holders of a majority in principal amount of the outstanding Notes by written notice to the Company and to the Trustee may waive all past defaults with respect to the Notes and rescind and annul a declaration of acceleration with respect to the Notes and its consequences if:
(i)    all existing Events of Default applicable to the Notes, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by the declaration of acceleration, have been cured or waived; and
(ii)    the rescission would not conflict with any judgment or decree of a court of competent jurisdiction.

SECTION 6.03    Other Remedies.  If an Event of Default with respect to the Notes occurs and is continuing, the Trustee may pursue, in its own name or as trustee of an express trust, any available remedy by proceeding at law or in equity to collect the payment of principal of, premium, if any, and interest on the Notes or to enforce the performance of any provision of the Notes or the Indenture.  The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of them in the proceeding.  When the Trustee Incurs expenses or renders services after the occurrence of an act of bankruptcy with respect to the Company, the expenses and the compensation for such services are intended to constitute expenses of administration under any federal or state bankruptcy, insolvency, arrangement, moratorium, reorganization or other debtor relief law.

SECTION 6.04    Waiver of Past Defaults.  Except as otherwise provided in Sections 6.02, 6.07 and 9.02, the Holders of a majority in principal amount of outstanding Notes may, by notice to the Trustee, waive an existing Default with respect to the Notes and its consequences.  Upon such waiver, the Default with respect to the Notes will cease to exist, and any Event of Default arising therefrom will be deemed to have been cured, but no such waiver will extend to any subsequent or other Default or impair any right consequent thereon.

SECTION 6.05    Control by Majority.  The Holders of at least a majority in aggregate principal amount of outstanding Notes may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee.  However, the Trustee may refuse to follow any direction that conflicts with law or the Indenture, that may involve the Trustee in personal liability, or that the Trustee determines in good faith may be unduly prejudicial to the rights of Holders of the Notes 

33

not joining in the giving of such direction, and may take any other action it deems proper that is not inconsistent with any such direction received from Holders of the Notes.

SECTION 6.06    Limitation on Suits.  A Holder of the Notes may not institute any proceeding, judicial or otherwise, with respect to the Indenture or the Notes, or for the appointment of a receiver or trustee, or for any other remedy under the Indenture or the Notes, unless:
(i)    such Holder has previously given to the Trustee written notice of a continuing Event of Default with respect to the Notes;
(ii)    the Holders of at least 25% in aggregate principal amount of outstanding Notes have made written request to a Responsible Officer of the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee under the Indenture;
(iii)    such Holder or Holders have offered to the Trustee indemnity reasonably satisfactory to the Trustee against any costs, liabilities or expenses to be Incurred in compliance with such request;
(iv)    the Trustee for 60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding; and
(v)    during such 60-day period, the Holders of a majority in aggregate principal amount of the outstanding Notes have not given the Trustee a direction that is inconsistent with such written request.

SECTION 6.07    Rights of Holders to Receive Payment.  Notwithstanding anything to the contrary, the right of a Holder of a Note to receive payment of principal of, premium, if any, or interest on its Note on or after the stated maturities thereof, or to bring suit for the enforcement of any such payment on or after such respective dates, may not be impaired or affected without the consent of that Holder.

SECTION 6.08    Collection Suit by Trustee.  If an Event of Default in payment of principal, premium, if any, or interest specified in clause (1) or (2) of Section 6.01 occurs and is continuing with respect to the Notes, the Trustee may recover judgment in its own name and as trustee of an express trust for the whole amount of principal, premium, if any, and accrued interest remaining unpaid on the Notes, together with interest on overdue principal and, to the lawful, overdue installments of interest, in each case at the rate specified in the Notes, and such further amount as is sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel and any other amounts due the Trustee hereunder.

34

SECTION 6.09    Trustee May File Proofs of Claim.  The Trustee may file proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee hereunder) and the Holders allowed in any judicial proceedings relating to the Company or its creditors or property, and is entitled and empowered to collect, receive and distribute any money, securities or other property payable or deliverable upon conversion or exchange of the Notes or upon any such claims.  Any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee and, if the Trustee consents to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agent and counsel, and any other amounts due the Trustee hereunder.  Nothing in the Indenture will be deemed to empower the Trustee to authorize or consent to, or accept or adopt on behalf of any Holder, any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.

SECTION 6.10    Priorities.  If the Trustee collects any money pursuant to this Article, it shall payout the money in the following order:
First:  to the Trustee for all amounts due to the Trustee hereunder;
Second: to Holders of the Notes in respect of which moneys have been collected for amounts then due and unpaid for principal of, premium, if any, and interest on such Notes, ratably, without preference or priority of any kind of any Note over any other Note, according to the amounts due and payable on such Notes for principal, premium, if any, and interest; and
Third: to the Company or as a court of competent jurisdiction may direct in a final, non-appealable order.
The Trustee, upon written notice to the Company, may fix a record date and payment date for any payment to Holders pursuant to this Section.

SECTION 6.11    Restoration of Rights and Remedies.  If the Trustee or any Holder has instituted a proceeding to enforce any right or remedy under the Indenture and the proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to the Holder, then, subject to any determination in the proceeding, the Company, the Trustee and the Holders will be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Company, the Trustee and the Holders will continue as though no such proceeding had been instituted.

35

SECTION 6.12    Undertaking for Costs.  In any suit for the enforcement of any right or remedy under the Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court may require any party litigant in such suit (other than the Trustee) to file an undertaking to pay the costs of the suit, and the court may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant (other than the Trustee) in the suit having due regard to the merits and good faith of the claims or defenses made by the party litigant.  This Section does not apply to a suit by the Trustee, a suit by a Holder to enforce payment of principal of or interest on any Note on the respective due dates, or a suit by Holders of more than 10% in principal amount of the outstanding Notes.

SECTION 6.13    Rights and Remedies Cumulative.  No right or remedy conferred or reserved to the Trustee or to the Holders under this Indenture is intended to be exclusive of any other right or remedy, and all such rights and remedies are, to the extent permitted by law, cumulative and in addition to every other right and remedy hereunder or now or hereafter existing at law or in equity or otherwise.  The assertion or exercise of any right or remedy hereunder, or otherwise, will not prevent the concurrent assertion or exercise of any other right or remedy.

SECTION 6.14    Delay or Omission Not Waiver.  No delay or omission of the Trustee or of any Holder to exercise any right or remedy accruing upon any Event of Default will impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein.  Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders, as the case may be.

SECTION 6.15    Waiver of Stay, Extension or Usury Laws.  The Company covenants, to the extent that it may lawfully do so, that it will not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law or any usury law or other law that would prohibit or forgive the Company from paying all or any portion of the principal of, premium, if any, or interest on the Notes as contemplated herein, wherever enacted, now or at any time hereafter in force, or that may affect the covenants or the performance of the Indenture.  The Company hereby expressly waives, to the extent that it may lawfully do so, all benefit or advantage of any such law and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.

ARTICLE 7 
THE TRUSTEE

SECTION 7.01    General.  (a)  The duties and responsibilities of the Trustee are as provided by the Trust Indenture Act and as set forth herein.  Whether or not expressly so 

36

provided, every provision of the Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee is subject to this Article.
(a)    Except during the continuance of an Event of Default, the Trustee needs to perform only those duties that are specifically set forth in the Indenture and no others, and no implied covenants or obligations will be read into the Indenture against the Trustee.  In the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein).  In case an Event of Default has occurred and is continuing, the Trustee shall exercise those rights and powers vested in it by the Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs.
(b)    No provision of the Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that
(1)    this Subsection shall not be construed to limit the effect of Subsection (a) of this Section;
(2)    the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts;
(3)    the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of a majority in principal amount of the Notes relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such series; and
(4)    no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it

37

SECTION 7.02    Certain Rights of Trustee.  Subject to Trust Indenture Act Sections 315(a) through (d):
(i)    In the absence of bad faith on its part, the Trustee may conclusively rely, and will be protected in acting or refraining from acting, upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper Person.  The Trustee need not investigate any fact or matter stated in the document, but, in the case of any document which is specifically required to be furnished to the Trustee pursuant to any provision hereof, the Trustee shall examine the document to determine whether it conforms to the requirements of the Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein).  The Trustee, in its discretion, may make further inquiry or investigation into such facts or matters as it sees fit and shall Incur no liability of any kind by reason of such inquiry or investigation.
(ii)    Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel conforming to Section 10.05 and the Trustee will not be liable for any action it takes or omits to take in good faith in reliance on the certificate or opinion.
(iii)    The Trustee may act through its attorneys and agents and will not be responsible for the misconduct or negligence of any agent appointed with due care.
(iv)    The Trustee will be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders of the Notes, unless such Holders have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities that might be Incurred by it in compliance with such request or direction.
(v)    The Trustee will not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within its rights or powers or for any action it takes or omits to take in accordance with the direction of the Holders of the Notes in accordance with Section 6.05 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under the Indenture.
(vi)    The Trustee may consult with counsel of its selection, and the advice of such counsel or any Opinion of Counsel will be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.

38

(vii)    No provision of the Indenture will require the Trustee to expend or risk its own funds or otherwise Incur any financial liability in the performance of its duties hereunder, or in the exercise of its rights or powers, unless it receives indemnity satisfactory to it against any loss, liability or expense.
(viii)    In no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.
(ix)    The Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities and this Indenture.
(x)    The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder.
(xi)    The Trustee shall not be liable for any action taken, suffered, or omitted to be taken by it in good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture.
(xii)    The Trustee may request that the Company deliver a certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture.

SECTION 7.03    Individual Rights of Trustee.  The Trustee, in its individual or any other capacity, may become the owner or pledgee of Notes and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not the Trustee.  Any Agent may do the same with like rights.  However, the Trustee is subject to Trust Indenture Act Sections 310(b) and 311.  For purposes of Trust Indenture Act Section 311(b)(4) and (6):
(a)    “Cash Transaction” means any transaction in which full payment for goods or securities sold is made within seven days after delivery of the goods or securities in currency or in checks or other orders drawn upon banks or bankers and payable upon demand; and
(b)    “Self-liquidating Paper” means any draft, bill of exchange, acceptance or obligation which is made, drawn, negotiated or Incurred for the purpose of financing the purchase, processing, manufacturing, shipment, storage or sale of goods, 

39

wares or merchandise and which is secured by documents evidencing title to, possession of, or a lien upon, the goods, wares or merchandise or the receivables or proceeds arising from the sale of the goods, wares or merchandise previously constituting the security, provided the security is received by the Trustee simultaneously with the creation of the creditor relationship arising from the making, drawing, negotiating or Incurring of the draft, bill of exchange, acceptance or obligation.

SECTION 7.04    Trustee’s Disclaimer.  The Trustee (i) makes no representation as to the validity or adequacy of the Indenture or the Notes, (ii) is not accountable for the Company’s use or application of the proceeds from the Notes and (iii) is not responsible for any statement in the Notes other than its certificate of authentication.

SECTION 7.05    Notice of Default.  If any Default with respect to the Notes occurs and is continuing and is known to the Trustee, the Trustee will send notice of the Default to each Holder within 90 days after it occurs, unless the Default has been cured; provided that, except in the case of a default in the payment of the principal of, premium, if any, or interest on any Note, the Trustee may withhold the notice if and so long as the board of directors, the executive committee or a trust committee of directors of the Trustee in good faith determines that withholding the notice is in the interest of the Holders of the Notes.  Notice to Holders under this Section will be given in the manner and to the extent provided in Trust Indenture Act Section 313(c).

SECTION 7.06    Reports by Trustee to Holders.  Within 60 days after each May 15, beginning with May 15, 2018, the Trustee will mail to each Holder, as provided in Trust Indenture Act Section 313(c), a brief report dated as of such May 15, if required by Trust Indenture Act Section 313(a), and file such reports with each stock exchange upon which its Notes are listed and with the Commission as required by Trust Indenture Act Section 313(d).

SECTION 7.07    Compensation and Indemnity.  (a)  The Company will pay the Trustee compensation as agreed upon in writing for its services.  The compensation of the Trustee is not limited by any law on compensation of a Trustee of an express trust.  The Company will reimburse the Trustee upon request for all reasonable out-of-pocket expenses, disbursements and advances Incurred or made by the Trustee, including the reasonable compensation and expenses of the Trustee’s agents and counsel.
(b)    The Company will indemnify the Trustee and Agents, for, and hold each of them harmless against, any loss, claim, damage, liability or expense Incurred by it without negligence or willful misconduct on its part arising out of or in connection with the acceptance or administration of the Indenture and its duties under the Indenture and the Notes, including the costs and expenses of defending itself against any claim or liability and of complying with any process served upon it or any of its officers in connection with the exercise or performance of any of its powers or duties under the Indenture and the Notes.

40

(c)    To secure the Company’s payment obligations in this Section, the Trustee will have a lien prior to the Notes on all money or property held or collected by the Trustee, in its capacity as Trustee, except money or property held in trust to pay principal, premium, if any, of, and interest on particular Notes.
(d)    When the Trustee incurs expenses or renders services in connection with an Event of Default, the expenses (including the reasonable charges and expenses of its counsel) and the compensation for the services are intended to constitute expenses of administration under any applicable Federal or state bankruptcy, insolvency or other similar law.
(e)    The provisions of this Section shall survive the termination of this Indenture.

SECTION 7.08    Replacement of Trustee.  (a)  (i)  The Trustee may resign at any time by written notice to the Company.
(ii)    The Holders of a majority in principal amount of all then outstanding Notes may remove the Trustee by written notice to the Trustee.
(iii)    If the Trustee is no longer eligible under Section 7.10 or in the circumstances described in Trust Indenture Act Section 310(b), any Holder that satisfies the requirements of Trust Indenture Act Section 310(b) may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.
(iv)    The Company may remove the Trustee if: (A) the Trustee is no longer eligible under Section 7.10; (B) the Trustee is adjudged a bankrupt or an insolvent; (C) a receiver or other public officer takes charge of the Trustee or its property; or (D) the Trustee becomes incapable of acting.
(v)    A resignation or removal of the Trustee and appointment of a successor Trustee will become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section.
(b)    If the Trustee has been removed by the Holders, Holders of a majority in principal amount of all then outstanding Notes may appoint a successor Trustee with the consent of the Company.  Otherwise, if the Trustee resigns or is removed, or if a vacancy exists in the office of Trustee for any reason, the Company will promptly appoint a successor Trustee.  If the successor Trustee does not deliver its written acceptance within 30 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of a majority in principal amount of all then outstanding Notes may petition at the expense of the Company any court of competent jurisdiction for the appointment of a successor Trustee.

41

(c)    Upon delivery by the successor Trustee of a written acceptance of its appointment to the retiring Trustee and to the Company, (i) the retiring Trustee upon payment of its charges hereunder will transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07, (ii) the resignation or removal of the retiring Trustee will become effective, and (iii) the successor Trustee will have all the rights, powers and duties of the Trustee under the Indenture.  Upon request of any successor Trustee, the Company will execute any and all instruments for fully and vesting in and confirming to the successor Trustee all such rights, powers and trusts.  The Company will give notice of any resignation and any removal of the Trustee and each appointment of a successor Trustee to all Holders, and include in the notice the name of the successor Trustee and the address of its Corporate Trust Office.
(d)    Notwithstanding replacement of the Trustee pursuant to this Section, the Company’s obligations under Section 7.07 will continue for the benefit of the retiring Trustee.
(e)    The Trustee agrees to give the notices provided for in, and otherwise comply with, Trust Indenture Act Section 310(b).

SECTION 7.09    Successor Trustee by Merger.  If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation or national banking association, the resulting, surviving or transferee corporation or national banking association without any further act will be the successor Trustee with the same effect as if the successor Trustee had been named as the Trustee in the Indenture.

SECTION 7.10    Eligibility.  The Indenture must always have a Trustee that satisfies the requirements of Trust Indenture Act Section 310(a) and has a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual report of condition.

SECTION 7.11    Money Held in Trust.  The Trustee will not be liable for interest on any money received by it except as it may agree with the Company.  Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law and except for money held in trust under Article 8.

ARTICLE 8 
DEFEASANCE AND DISCHARGE

SECTION 8.01    Satisfaction and Discharge of Indenture.  If at any time (a) the Company shall have paid or caused to be paid the principal of, premium, if any, and interest on all the Notes outstanding hereunder (other than Notes which have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.04) as and when the same shall have become due and payable, or (b) the Company shall have delivered to the Trustee for cancellation all Notes theretofore authenticated (other than any Notes which shall have been 

42

destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.04) or (c) (i) all the Notes not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and (ii) the Company shall have irrevocably deposited or caused to be deposited with the Trustee as trust funds the entire amount in cash (other than moneys repaid by the Trustee or any paying agent to the Company in accordance with Section 8.05) or U.S. Government Obligations, maturing as to principal and interest in such amounts and at such times as will insure the availability of cash sufficient to pay at maturity or upon redemption of all Notes (other than any Notes which shall have been destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.04) not theretofore delivered to the Trustee for cancellation, including principal and interest due or to become due on or prior to such date of maturity as the case may be, and if, in any such case, the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to the Notes, then this Indenture shall cease to be of further effect with respect to the Notes (except as to (i) rights of registration of transfer and exchange of securities of such, and the Company’s right of optional redemption, (ii) substitution of mutilated, defaced, destroyed, lost or stolen Notes, (iii) rights of Holders of Notes to receive payments of principal, and premium, if any, thereof and interest thereon, upon the original stated due dates therefor (but not upon acceleration) and remaining rights of the Holders of Notes to receive mandatory sinking fund payments, if any, (iv) the rights, obligations and immunities of the Trustee hereunder and (v) the rights of the Holders of Notes as beneficiaries hereof with respect to the property so deposited with the Trustee payable to all or any of them), and the Trustee, on demand of the Company accompanied by an Officers’ Certificate and an Opinion of Counsel and at the cost and expense of the Company, shall execute proper instruments acknowledging such satisfaction of and discharging this Indenture; provided that the rights of Holders of Notes to receive amounts in respect of principal of, premium, if any, and interest on the Notes held by them shall not be delayed longer than required by then-applicable mandatory rules or policies of any securities exchange upon which the Notes are listed.  The Company agrees to reimburse the Trustee for any costs or expenses thereafter reasonably and properly Incurred and to compensate the Trustee for any services thereafter reasonably and properly rendered by the Trustee in connection with this Indenture or the Notes.

SECTION 8.02    Defeasance and Discharge of Indenture.  The Company shall be deemed to have paid and shall be discharged from any and all obligations in respect of the Notes, on the 123rd day after the deposit referred to in clause (A) of this Section 8.02 has been made with respect to the Notes, and the provisions of this Indenture shall no longer be in effect with respect to the Notes (and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging the same), except as to: (a) rights of registration of transfer and exchange, and the Company’s right of optional redemption, (b) substitution of apparently mutilated, defaced, destroyed, lost or stolen Notes, (c) rights of holders to receive payments of principal thereof, premium, if any, and interest thereon, upon the original stated due dates therefor (but not upon acceleration), (d) the rights, obligations and immunities of the Trustee 

43

hereunder and (e) the rights of the Holders as beneficiaries hereof with respect to the property so deposited with the Trustee payable to all or any of them; provided that the following conditions shall have been satisfied:
(A)    with reference to this provision the Company has deposited or caused to be irrevocably deposited with the Trustee (or another trustee satisfying the requirements of Sections 7.08 and 7.10) as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Notes, (i) money in an amount, or (ii) U.S. Government Obligations which through the payment of interest and principal in respect thereof in accordance with their terms will provide not later than one day before the due date of any payment referred to in subclause (x) or (y) of this clause (A) money in an amount, or (iii) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge without consideration of the reinvestment of such interest and after payment of all federal, state and local taxes or other charges and assessments in respect thereof payable by the Trustee (x) the principal of, premium, if any, and each installment of interest on the outstanding Notes on the due dates thereof and (y) any mandatory sinking fund payments or analogous payments applicable to the Notes on the day on which such payments are due and payable in accordance with the terms of the Notes and the Indenture with respect to the Notes;
(B)    the Company has delivered to the Trustee (i) either (x) an Opinion of Counsel to the effect that beneficial owners of the Notes will not recognize income, gain or loss for federal income tax purposes as a result of the Company’s exercise of its option under this Section 8.02 and will be subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred, which Opinion of Counsel must be based upon a ruling of the Internal Revenue Service to the same effect or a change in applicable federal income tax law or related treasury regulations after the date of this Indenture or (y) a ruling directed to the Company received from the Internal Revenue Service to the same effect as the aforementioned Opinion of Counsel and (ii) an Opinion of Counsel to the effect that the creation of the defeasance trust does not violate the Investment Company Act of 1940, as amended, and after the passage of 123 days following the deposit, the trust fund will not be subject to the effect of Section 547 of the U.S. Bankruptcy Code or Section 15 of the New York Debtor and Creditor Law;
(C)    immediately after giving effect to such deposit on a pro forma basis, no Event of Default with respect to such Notes, or event that after the 

44

giving of notice or lapse of time or both would become an Event of Default with respect to such Notes, shall have occurred and be continuing on the date of such deposit or during the period ending on the 123rd day after the date of such deposit, and such deposit shall not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which the Company is a party or by which the Company is bound; and
(D)    if at such time the Notes are listed on a national securities exchange, the Company has delivered to the Trustee an Opinion of Counsel to the effect that the Notes will not be delisted as a result of such deposit, defeasance and discharge.
If the Company shall be deemed to have paid and shall be discharged from any and all obligations in respect of all of the Notes pursuant to this Section 8.02 and all amounts outstanding to the Trustee hereunder or the Collateral Agent under the Pledge Agreement shall have been paid in full, then the Company shall be released of its obligations under the Pledge Agreement and the Collateral shall be released from the security interest granted in favor of the Collateral Agent thereunder.

SECTION 8.03    Defeasance of Certain Obligations.  The Company may omit to comply with any term, provision or condition set forth in, and this Indenture will no longer be in effect with respect to, any covenant in Article 4 or Section 5.01 and clauses (iii), (iv) and (vii) of Section 6.01 and Article 11 shall be deemed not to be an Event of Default, if:
(A)    with reference to this Section 8.03, the Company has deposited or caused to be irrevocably deposited with the Trustee (or another trustee satisfying the requirements of Section 7.08) as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Notes, (i) money in an amount or (ii) U.S. Government Obligations which through the payment of principal and interest in respect thereof in accordance with their terms will provide not later than one day before the due dates thereof or earlier redemption (irrevocably provided for under agreements satisfactory to the Trustee), as the case may be, of any payment referred to in subclause (x) or (y) of this clause (A) money in an amount, or (iii) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge without consideration of the reinvestment of such interest and after payment of all federal, state and local taxes or other charges and assessments in respect thereof payable by the Trustee (x) the principal of, premium, if any, and each installment of interest on the outstanding Notes on the due date thereof or earlier redemption (irrevocably provided for under arrangements satisfactory to the Trustee), as the case may be, and (y) any 

45

mandatory sinking fund payments or analogous payments applicable to the Notes and the Indenture with respect to the Notes on the day on which such payments are due and payable in accordance with the terms of the Notes and the Indenture with respect to the Notes;
(B)    the Company has delivered to the Trustee (i) an Opinion of Counsel to the effect that the beneficial owners will not recognize income, gain or loss for federal income tax purposes as a result of the Company’s exercise of its option under this Section 8.03 and will be subject to federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred and (ii) an Opinion of Counsel to the effect that the creation of the defeasance trust does not violate the Investment Company Act of 1940 and after the passage of 123 days following the deposit, the trust fund will not be subject to the effect of Section 547 of the U.S. Bankruptcy Code or Section 15 of the New York Debtor and Creditor Law;
(C)    immediately after giving effect to such deposit on a pro forma basis, no Event of Default or event that after the giving of notice or lapse of time or both would become an Event of Default shall have occurred and be continuing on the date of such deposit or during the period ending on the 123rd day after the date of such deposit, and such deposit shall not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which the Company is a party or by which the Company is bound; and
(D)    if at such time the Notes are listed on a national securities exchange, the Company has delivered to the Trustee an Opinion of Counsel to the effect that such Notes will not be delisted as a result of such deposit, defeasance and discharge.
If the Company shall have satisfied each of the conditions set forth above in this Section 8.03 and all amounts outstanding to the Trustee hereunder or the Collateral Agent under the Pledge Agreement shall have been paid in full, then the Company shall be released of its obligations under the Pledge Agreement and the Collateral shall be released from the security interest granted in favor of the Collateral Agent thereunder.

SECTION 8.04    Application of Trust Money.  Subject to Section 8.05, the Trustee will hold in trust the money or U.S. Government Obligations deposited with it pursuant to Sections 8.01, 8.02 or 8.03, and apply the deposited money and the proceeds from deposited U.S. Government Obligations to the payment of principal of, premium, if any, and interest on the Notes in accordance with such Notes and the Indenture.  Such money and U.S. Government Obligations need not be segregated from other funds except to the extent required by law.

46

SECTION 8.05    Repayment to Company.  Subject to Sections 7.07, 8.01, 8.02 and 8.03, the Trustee will promptly pay to the Company upon request any excess money held by the Trustee at any time and thereupon be relieved from all liability with respect to such money.  The Trustee will pay to the Company upon request any money held for payment with respect to the Notes that remains unclaimed for two years, provided that before making such payment the Trustee may at the expense of the Company publish once in a newspaper of general circulation in New York City, or send to each Holder of the Notes entitled to such money, notice that the money remains unclaimed and that after a date specified in the notice (at least 30 days after the date of the publication or notice) any remaining unclaimed balance of money will be repaid to the Company.  After payment to the Company, Holders of the Notes entitled to such money must look solely to the Company for payment, unless applicable law designates another Person, and all liability of the Trustee with respect to such money will cease.

SECTION 8.06    Reinstatement.  If and for so long as the Trustee is unable to apply any money or U.S. Government Obligations held in trust pursuant to Sections 8.01, 8.02 or 8.03 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under the Indenture and the Notes will be reinstated as though no such deposit in trust had been made.  If the Company makes any payment of principal of, premium, if any, or interest on the Notes because of the reinstatement of its obligations, it will be subrogated to the rights of the Holders of such Notes to receive such payment from the money or U.S. Government Obligations held in trust.

ARTICLE 9 
AMENDMENTS, SUPPLEMENTS AND WAIVERS

SECTION 9.01    Amendments Without Consent of Holders.  (a) The Company and the Trustee may amend or supplement the Indenture or the Notes without notice to or the consent of any Noteholder
(i)    to cure any ambiguity, defect or inconsistency in the Indenture or the Notes;
(ii)    to comply with Section 5.01;
(iii)    to comply with any requirements of the Commission in connection with the qualification of the Indenture under the Trust Indenture Act;
(iv)    to evidence and provide for the acceptance of appointment hereunder by a successor Trustee;
(v)    to provide for uncertificated Notes in addition to or in place of certificated Notes, provided that the uncertified Notes are issued in registered form for 

47

purposes of Section 163(f) of the Code, or in a manner such that the uncertificated Notes are described in Section 163(f)(2)(B) of the Code;
(vi)    to provide for any guarantee of the Notes, to secure-the Notes or to confirm and evidence the release, termination or discharge of any guarantee of or lien securing the Notes when such release, termination or discharge is permitted by the Indenture;
(vii)    to provide for or confirm the issuance of Additional Notes; or
(viii)    to make any other change that does not materially and adversely affect the rights of any Holder.

SECTION 9.02    Amendments With Consent of Holders.  (a)  Except as otherwise provided in Sections 6.02, 6.04 and 6.07 or paragraph (b), the Company and the Trustee may amend the Indenture with respect to the Notes and the Notes with the written consent of the Holders of a majority in principal amount of the outstanding Notes, and the Holders of a majority in principal amount of the outstanding Notes by written notice to the Trustee may waive future compliance by the Company with any provision of the Indenture with respect to the Notes or the Notes.
(b)    Notwithstanding the provisions of paragraph (a), without the consent of each Holder of Notes affected, an amendment or waiver may not:
(i)    reduce the principal amount of or change the stated maturity of any installment of principal of any Note;
(ii)    reduce the rate of or change the stated maturity of any interest payment on any Note;
(iii)    reduce the amount payable upon the redemption or any required repurchase of any Note or change the times at which any Note may be redeemed or repurchased or, once notice of redemption or a Change of Control Offer has been given, the time at which it must thereupon be redeemed or repurchased;
(iv)    make any Note payable in money other than that stated in such Note;
(v)    impair the right of any Holder of Notes to receive any principal payment, premium payment, if any, or interest payment on such Holder’s Notes, on or after the stated maturity thereof, or to institute suit for the enforcement of any such payment;

48

(vi)    make any change in the percentage of the principal amount of the Notes required for amendments or waivers; or
(vii)    modify or change any provision of the Indenture affecting the ranking of the Notes in a manner adverse to the Holders of the Notes.
(c)    It is not necessary for Noteholders to approve the particular form of any proposed amendment, supplement or waiver, but is sufficient if their consent approves the substance thereof.
(d)    An amendment, supplement or waiver under this Section will become effective on receipt by the Trustee of written consents from the Holders of the requisite percentage in principal amount of the outstanding Notes.  After an amendment, supplement or waiver under this Section becomes effective, the Company will send to the Holders affected thereby a notice briefly describing the amendment, supplement or waiver.  The Company will send supplemental indentures to Holders upon request.  Any failure of the Company to send such notice, or any defect therein, will not, however, in any way impair or affect the validity of any such supplemental indenture or waiver.

SECTION 9.03    Effect of Consent.  (a)  After an amendment, supplement or waiver becomes effective, it will bind every Holder of Notes unless it is of the type requiring the consent of each Holder affected.  If the amendment, supplement or waiver is of the type requiring the consent of each Holder affected, the amendment, supplement or waiver will bind each Holder that has consented to it and every subsequent Holder of a Note that evidences the same debt as the Note of the consenting Holder.
(b)    If an amendment, supplement or waiver changes the terms of a Note, the Trustee may require the Holder to deliver it to the Trustee so that the Trustee may place an appropriate notation of the changed terms on the Note and return it to the Holder, or exchange it for a new Note that reflects the changed terms.  The Trustee may also place an appropriate notation on any Note thereafter authenticated.  However, the effectiveness of the amendment, supplement or waiver is not affected by any failure to annotate or exchange Notes in this fashion.

SECTION 9.04    Trustee’s Rights and Obligations.  The Trustee shall be provided with, and will be fully protected in relying upon, an Opinion of Counsel and an Officer’s Certificate each stating that the execution of any amendment, supplement or waiver authorized pursuant to this Article is authorized or permitted by the Indenture.  Upon receipt of such an Opinion of Counsel and Officer’s Certificate, it shall sign the amendment, supplement or waiver so long as the same does not adversely affect the rights of the Trustee.  The Trustee may, but is not obligated to, execute any amendment, supplement or waiver that affects the Trustee’s own rights, duties or immunities under the Indenture.

49

SECTION 9.05    Conformity with Trust Indenture Act.  Every supplemental indenture executed pursuant to this Article shall conform to the requirements of the Trust Indenture Act.

50

SECTION 9.06    Payments for Consents.  Neither the Company nor any of its Subsidiaries or Affiliates may, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of the Indenture with respect to the Notes or the Notes unless such consideration is offered to be paid, or agreed to be paid to all Holders of the Notes that consent, waive or agree to amend such term or provision within the time period set forth in the solicitation documents relating to the consent, waiver or amendment.

ARTICLE 10 
MISCELLANEOUS

SECTION 10.01    Trust Indenture Act of 1939.  The Indenture shall incorporate and be governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act.

SECTION 10.02    Noteholder Communications; Noteholder Actions.  (a)  The rights of Holders to communicate with other Holders with respect to the Indenture or the Notes are as provided by the Trust Indenture Act, and the Company and the Trustee shall comply with the requirements of Trust Indenture Act Sections 312(a) and 312(b).  Neither the Company nor the Trustee will be held accountable by reason of any disclosure of information as to names and addresses of Holders made pursuant to the Trust Indenture Act.
(b)    (i)    Any request, demand, authorization, direction, notice, consent to amendment, supplement or waiver or other action provided by this Indenture to be given or taken by a Holder (an “Act”) may be evidenced by an instrument signed by the Holder delivered to the Trustee.  The fact and date of the execution of the instrument, or the authority of the person executing it, may be proved in any manner that the Trustee deems sufficient.
(ii)    The Trustee may make reasonable rules for action by or at a meeting of Holders of Notes, which will be binding on all the Holders of Notes.
(c)    Any Act by the Holder of any Note binds that Holder and every subsequent Holder of a Note that evidences the same debt as the Note of the acting Holder, even if no notation thereof appears on the Note.  Subject to paragraph (d), a Holder may revoke an Act as to its Notes, but only if the Trustee receives the notice of revocation before the date the amendment or waiver or other consequence of the act becomes effective.
(d)    The Company may, but is not obligated to, fix a record date (which need not be within the time limits otherwise prescribed by Trust Indenture Act Section 316(c)) for the purpose of determining the Holders of Notes entitled to Act with respect to any amendment or waiver or in any other regard, except that during the continuance of an Event of Default with respect to the Notes, only the Trustee may set a record date as to notices of default, any declaration or acceleration or any other remedies or other consequences of such Event of 

51

Default.  If a record date is fixed with respect to the Notes, those Persons that were Holders of Notes at such record date and only those Persons will be entitled to act, or to revoke any previous act, whether or not those Persons continue to be Holders of Notes after the record date.  No Act will be valid or effective for more than 90 days after the record date.

SECTION 10.03    Notices.  (a)  Any notice or communication to the Company will be deemed given if in writing (i) when delivered in person or (ii) five days after mailing when mailed by first class mail, or (iii) when sent by facsimile transmission, with transmission confirmed.  Any notice to the Trustee will be effective only upon receipt.  In each case the notice or communication should be addressed as follows:
if to the Company:
IPALCO Enterprises, Inc.   
One Monument Circle  
Indianapolis, Indiana 46204 
Fax:  (317) 261-8288 
Attention:  General Counsel
if to the Trustee:
U.S. Bank National Association  
10 W. Market Street, Suite 1150  
Indianapolis, IN 46204 
Attention: Global Corporate Trust Services
The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications.
(b)    Except as otherwise expressly provided with respect to published notices, any notice or communication to a Holder will be deemed given when mailed to the Holder at its address as it appears on the Register by first class mail or, as to any Global Note registered in the name of DTC or its nominee, as agreed by the Company, the Trustee and DTC.  Copies of any notice or communication to a Holder, if given by the Company, will be mailed to the Trustee at the same time.  Defect in mailing a notice or communication to any particular Holder will not affect its sufficiency with respect to other Holders.
(c)    Where the Indenture provides for notice, the notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and the waiver will be the equivalent of the notice.  Waivers of notice by Holders must be filed with the Trustee, but such filing is not a condition precedent to the validity of any action taken in reliance upon such waivers.

52

SECTION 10.04    Certificate and Opinion as to Conditions Precedent.  Upon any request or application by the Company to the Trustee to take any action under the Indenture, the Company will furnish to the Trustee:
(i)    an Officers’ Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in the Indenture relating to the proposed action have been complied with; and
(ii)    an Opinion of Counsel stating that all such conditions precedent have been complied with.

SECTION 10.05    Statements Required in Certificate or Opinion.  Each certificate or opinion with respect to compliance with a condition or covenant provided for in the Indenture must include:
(i)    a statement that each person signing the certificate or opinion has read the covenant or condition and the related definitions;
(ii)    a brief statement as to the nature and scope of the examination or investigation upon which the statement or opinion contained in the certificate or opinion is based;
(iii)    a statement that, in the opinion of each such person, that person has made such examination or investigation as is necessary to enable the person to express an informed opinion as to whether or not such covenant or condition has been complied with; and
(iv)    a statement as to whether or not, in the opinion of each such person, such condition or covenant has been complied with, provided that an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials with respect to matters of fact.

SECTION 10.06    Payment Date Other Than a Business Day.  If any payment with respect to a payment of any principal of, premium, if any, or interest on any Note (including any payment to be made on any date fixed for redemption or purchase of any Note) is due on a day which is not a Business Day, then the payment need not be made on such date, but may be made on the next Business Day with the same force and effect as if made on such date, and no interest will accrue for the intervening period.

SECTION 10.07    Governing Law.  The Indenture and the Notes shall be governed by, and construed in accordance with, the laws of the State of New York.

SECTION 10.08    No Adverse Interpretation of Other Agreements.  The Indenture may not be used to interpret another indenture or loan or debt agreement of the Company or any 

53

Subsidiary of the Company, and no such indenture or loan or debt agreement may be used to interpret the Indenture.

SECTION 10.09    Successors.  All agreements of the Company in the Indenture and the Notes will bind its successors.  All agreements of the Trustee in the Indenture will bind its successor.

SECTION 10.10    Duplicate Originals.  The parties may sign any number of copies of the Indenture.  Each signed copy shall be an original, but all of them together represent the same agreement.

SECTION 10.11    Separability.  In case any provision in the Indenture or in the Notes is invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired thereby.

SECTION 10.12    Table of Contents and Headings.  The Table of Contents, Cross-Reference Table and headings of the Articles and Sections of the Indenture have been inserted for convenience of reference only, are not to be considered a part of the Indenture and in no way modify or restrict any of the terms and provisions of the Indenture.

SECTION 10.13    No Liability of Directors, Officers, Employees, Incorporators and Stockholders.  No director, officer, employee, incorporator or stockholder of the Company, as such, will have any liability for any obligations of the Company under the Notes, or the Indenture or for any claim based on, in respect of, or by reason of, such obligations.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.

SECTION 10.14    Waiver of Jury Trial.  EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY.

SECTION 10.15    Force Majeure.  In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.

54

ARTICLE 11 
SECURITY AND COLLATERAL

SECTION 11.01    Pledge Agreement.  The full and punctual payment when due and the full and punctual performance of all of the obligations of the Company under the Notes and this Indenture to the Holders and the Trustee, according to the provisions of this Indenture or the Notes (the “Obligations”), shall be secured, as provided in the Pledge Agreement.  Each Holder of the Notes, by its acceptance thereof, consents and agrees to the terms of the Pledge Agreement (including, without limitation, the provisions providing for foreclosure and release of Collateral) as the same may be in effect or may be amended from time to time in accordance  with its terms and authorizes and directs the Collateral Agent to enter into the Pledge Agreement and to perform its obligations and exercise its rights thereunder in accordance therewith.  The Company shall deliver to the Trustee copies of all documents delivered to the Collateral Agent pursuant to the Pledge Agreement, and shall cause to be done all such acts and things as may be necessary or proper, or as may be required by the provisions of the Pledge Agreement, to assure and confirm to the Trustee and the Collateral Agent that the security interest in the Collateral contemplated hereby, by the Pledge Agreement or any parts thereof, as from time to time constituted, so as to render the same available for the security and benefit of this Indenture and the Notes, secured hereby, according to the intent and purposes herein expressed.  The Company shall cause to be taken any and all actions reasonably required to cause the Pledge Agreement to create and maintain, as security for the Obligations of the Company, hereunder, a valid and enforceable perfected Lien in and on all the Collateral, in favor of the Collateral Agent for the benefit of the Trustee and Holders and other Secured Parties (as defined in the Pledge Agreement), if any, and subject to no other Liens other than Liens permitted by Section 4.03(a) hereof.

SECTION 11.02    Recording and Opinions.  The Company shall comply with the provisions of Section 314(b) of the Trust Indenture Act, including the delivery to the Trustee of any opinions relating to the perfection of the security interest in the Collateral created by the Pledge Agreement, to the extent required thereby.

SECTION 11.03    Release of Collateral.  (a)  Subject to subsections (b), (c) and (d) of this Section 11.03 and the terms of the Pledge Agreement, Collateral may be released from the Lien and security interest created by the Pledge Agreement at any time or from time to time in accordance with the provisions of the Pledge Agreement.  In addition, subject to the terms of the Pledge Agreement, upon the request of the Company pursuant to an Officers’ Certificate certifying that all conditions precedent hereunder have been met (at the sole cost and expense of the Company), the Collateral Agent shall release the Collateral that is sold, conveyed or disposed of in compliance with the provisions of the Pledge Agreement and this Indenture.  Upon receipt of such Officers’ Certificate, the Collateral Agent shall execute, deliver or acknowledge any necessary or proper instruments of termination, satisfaction or release to evidence the release of 

55

any Collateral permitted to be released pursuant to this Indenture or the Pledge Agreement, as prepared by the Company.
(b)    No Collateral shall be released from the Lien and security interest created by the Pledge Agreement pursuant to the provisions of the Pledge Agreement unless there shall have been delivered to the Collateral Agent the certificate required by this Section 11.03.
(c)    At any time when a Default or Event of Default with respect to the Notes shall have occurred and be continuing and the maturity of the Notes shall have been accelerated (whether by declaration or otherwise) and the Trustee shall have delivered a notice of acceleration to the Collateral Agent, no release of Collateral pursuant to the provisions of the Pledge Agreement shall be effective as against the Holders of Notes.
(d)    The release of any Collateral from the terms of this Indenture and the Pledge Agreement shall not be deemed to impair the security under this Indenture in contravention of the provisions hereof if and to the extent the Collateral is released pursuant to the terms of this Indenture or the terms of the Pledge Agreement.  To the extent applicable, the Company shall cause TIA Section 313(b), relating to reports, and TIA Section 314(d), relating to the release of property or securities from the Lien and security interest of the Pledge Agreement and relating to the substitution therefor of any property or securities to be subjected to the Lien and security interest of the Pledge Agreement, to be complied with.  Any certificate or opinion required by TIA Section 314(d) may be made by an Officer of the Company except in cases where TIA Section 314(d) requires that such certificate or opinion be made by an independent Person, which Person shall be an independent engineer, appraiser or other expert selected by the Company in a manner consistent with the requirements of the TIA.

SECTION 11.04    Certificates of the Company.  The Company shall furnish to the Trustee and the Collateral Agent, prior to each proposed release of Collateral pursuant to the Pledge Agreement, (i) all documents required by TIA Section 314(d) and (ii) an Opinion of Counsel, which may be rendered by internal counsel to the Company to the effect that such accompanying documents constitute all documents required by TIA Section 314(d).

SECTION 11.05    Certificates of the Trustee.  In the event that the Company wishes to release Collateral in accordance with the Pledge Agreement and has delivered the certificates and documents required by the Pledge Agreement and Sections 11.03 and 11.04 hereof and the Trustee has received, all documentation required by TIA Section 314(d) in connection with such release, and the Opinion of Counsel delivered pursuant to Section 11.04, the Trustee shall deliver a certificate to the Collateral Agent setting forth that it has received all such documentation.

SECTION 11.06    Authorization of Actions To Be Taken by the Collateral Agent Under the Pledge Agreement.  Subject to the provisions of Sections 7.01 and 7.02 hereof and the Pledge Agreement, the Trustee may, with the consent of the Holders of a majority in principal 

56

amount of the Notes direct the Collateral Agent to take all actions it deems necessary or appropriate in order to (a) enforce any of the terms of the Pledge Agreement and (b) collect and receive any and all amounts payable in respect of the Obligations of the Company hereunder.

SECTION 11.07    Authorization of Receipt of Refunds by the Trustee Under the Pledge Agreement.  The Trustee is authorized to receive any funds distributed under the Pledge Agreement for the benefit of all Holders, and to make further distributions of such funds to the Holders of Notes according to the provisions of this Indenture.

SECTION 11.08    Termination of Security Interest.  Upon the payment in full of all Obligations of the Company, under this Indenture and the Notes, or upon defeasance or covenant defeasance pursuant to Sections 8.01, 8.02 or 8.03 hereof, respectively, the Trustee shall, upon receipt of an Officer’s Certificate, deliver a certificate to the Collateral Agent to such effect, and, subject to the terms of the Pledge Agreement, instruct the Collateral Agent to release the Liens pursuant to this Indenture and the Pledge Agreement.

SIGNATURES
IN WITNESS WHEREOF, the parties hereto have caused the Indenture to be duly executed as of the date first written  above.
IPALCO ENTERPRISES, INC. 
as Issuer
		
	By:
	 /s/ Craig L. Jackson     
Name:    Craig L. Jackson 
Title:    Chief Financial Officer

U.S. BANK NATIONAL ASSOCIATION, 
as Trustee
		
	By:
	  /s/ Rebekah A. Foltz     
Name:    Rebekah A. Foltz 
Title:    Vice President

57

EXHIBIT A
[FACE OF NOTE]
IPALCO Enterprises, Inc.
3.70% Senior Secured Note Due 2024
[CUSIP] [144A]:_______                  
[ISIN] [144A]:  ________
[CUSIP] [Reg S]: ________  
[ISIN] [Reg S]: ________

No.
$
IPALCO Enterprises, Inc., an Indiana corporation (the “Company”, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to [Cede & Co.], or its registered assigns, the principal sum 
of                                               Dollars ($                    ) [or such other amount as indicated on the Schedule of Exchange of Notes attached hereto] on September 1, 2024.
Interest Rate:  3.70% per annum
Interest Payment Dates:  March 1 and September 1, commencing March 1, 2018.
Regular Record Dates:  February 15 and August 15. 
Reference is hereby make to the further provisions of this Note set forth on the reverse hereof, which will for all purposes have the same effect as if set forth at this place.
IN WITNESS WHEREOF, the Company has caused this Note to be signed manually or by facsimile by its duly authorized officer.

A-1

IPALCO ENTERPRISES, INC.
		
	By:
	         
Name: 
Title:

A-2

(Form of Trustee’s Certificate of Authentication)
This is one of the 3.70% Senior Secured Notes Due 2024 described in the Indenture referred to in this Note.
U.S. Bank National Association,  
as Trustee

		
	By:
	         
Authorized Signatory

Date of Authentication:      
 

A-3

[REVERSE SIDE OF NOTE]
IPALCO Enterprises, Inc.
3.70% Senior Secured Note Due 2024
1.    Principal and Interest.
The Company promises to pay the principal of this Note on September 1, 2024.
The Company promises to pay interest on the principal amount of this Note on each interest payment date, as set forth on the face of this Note, and at maturity at the rate of 3.70% per annum.
Interest will be payable semiannually (to the holders of record of the Notes at the close of business on the February 15 or August 15 immediately preceding the interest payment date) on each interest payment date, commencing March 1, 2018.
Interest on this Note will accrue from the most recent date to which interest has been paid on this Note (or, if there is no existing default in the payment of interest and if this Note is authenticated between a regular record date and the next interest payment date, from such interest payment date) or, if no interest has been paid, from the Issue Date.  Interest will be computed in the basis of a 360-day year of twelve 30-day months.
The Company will pay interest on overdue principal, premium, if any, and, to the extent lawful, interest at a rate per annum that is 1% in excess of 3.70%.  Interest not paid when due and any interest on principal, premium or interest not paid when due will be paid to the Persons that are Holders on a special record date, which will be the 15th day preceding the date fixed by the Company for the payment of such interest, whether or not such day is a Business Day.  At least 15 days before a special record date, the Company will send to each Holder and to the Trustee a notice that sets forth the special record date, the payment date and the amount of interest to be paid.
2.    Indenture.
This is one of the Notes designated as “3.70% Senior Secured Notes due 2024” (the “Notes”) issued under an indenture dated as of August 22, 2017 (as amended from time to time) (the “Indenture”) between the Company and U.S. Bank National Association, as Trustee, (the “Trustee”).  Capitalized terms used herein are used as defined in the Indenture unless otherwise indicated.  The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act.  The Notes are subject to all such terms, and Holders are referred to the Indenture and the Trust Indenture Act for a statement of all such terms.  To the extent permitted by applicable law, in the event of any 

A-4

inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture will control.
The Notes are general unsubordinated obligations of the Company.  The Notes are secured by a pledge by the Company of all of the outstanding common stock of the Company’s principal subsidiary, Indianapolis Power & Light Company, pursuant to a Pledge Agreement Supplement dated August 22, 2017 between the Company and The Bank of New York Mellon Trust Company, N.A., as Collateral Agent, which supplements the Pledge Agreement dated as of November 14, 2001 between the Company and the Collateral Agent.  The Indenture limits the original aggregate principal amount of the Notes to $405,000,000, but Additional Notes may be issued pursuant to the Indenture, and the originally issued Notes and all such Additional Notes will be considered the same series of Notes.
3.    Repurchase of Notes Upon a Change of Control.
Upon the occurrence of a Change of Control Triggering Event, the Holder of this Note will have the right to require the Company to repurchase all or any part (no note of a principal amount of $2,000 or less will be repurchased in part) of this Note at a repurchase price in cash equal to 101% of the principal amount of this Note plus accrued and unpaid interest, if any, to, but not including, the date of repurchase, as further described in the Indenture.
4.    Redemption; Discharge Prior to Redemption or Maturity.
This Note is subject to optional redemption, as further described in the Indenture. There is no sinking fund or mandatory redemption applicable to this Note.
If the Company deposits with the Trustee money or U.S. Government Obligations sufficient to pay the then outstanding principal of, premium, if any, and accrued interest on the Notes to redemption or maturity, the Company may in certain circumstances be discharged from the Indenture with respect to the Notes or may be discharged from certain of its obligations under certain provisions of the Indenture with respect to the Notes.
5.    Registered Form; Denominations; Transfer; Exchange.
The Notes are in registered form without coupons in minimum denominations of $2,000 principal amount and integral multiples of $1,000 in excess thereof.  A Holder may register the transfer or exchange of Notes in accordance with the Indenture.  The Trustee may require a Holder to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture.  Pursuant to the Indenture, there are certain periods during which the Trustee will not be required to issue, register the transfer of or exchange any Note or certain portions of a Note.
6.    Defaults and Remedies.

A-5

If an Event of Default, as defined in the Indenture, with respect to the Notes occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the Notes may declare all the Notes to be due and payable.  If a bankruptcy or insolvency default with respect to the Company occurs and is continuing, the Notes automatically become due and payable.  Holders of the Notes may not enforce the Indenture or the Notes except as provided in the Indenture.  The Trustee may require indemnity satisfactory to it before it enforces the Indenture or Notes.  Subject to certain limitations, Holders of a majority in principal amount of the Notes then outstanding may direct the Trustee in its exercise of remedies.
7.    Amendment and Waiver.
Subject to certain exceptions, the Indenture with respect to the Notes and such Notes may be amended, or default may be waived, with the consent of the Holders of a majority in principal amount of the outstanding Notes.  Without notice to or the consent of any Holder, the Company and the Trustee may amend or supplement the Indenture or the Notes to, among other things, cure any ambiguity, defect or inconsistency.
8.    Authentication.
This Note is not valid until the Trustee (or Authenticating Agent) signs the certificate of authentication on the other side of this Note.
9.    Abbreviations.
Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian) and U/G/M/A/ (=Uniform Gifts to Minors Act).
The Company will furnish a copy of the Indenture to any Holder upon written request and without charge.

A-6

[FORM OF TRANSFER NOTICE]
FOR VALUE RECEIVED the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto
Insert Taxpayer Identification No.
 
         
    Please print or typewrite name and address including zip code of assignee
 
         
    the within Note and all rights thereunder, hereby irrevocably constituting and appointing
attorney to transfer said Note on the books of the Company with full power of substitution in the premises.

A-7

[THE FOLLOWING PROVISION TO BE INCLUDED ON ALL  
CERTIFICATES BEARING A RESTRICTED LEGEND]
In connection with any transfer of this Note occurring prior to August 22, 2018 the undersigned confirms that such transfer is made without utilizing any general solicitation or general advertising and further as follows:
Check One
  ̈ (1) This Note is being transferred to a “qualified institutional buyer” in compliance with Rule 144A under the Securities Act of 1933, as amended and certification in the form of Exhibit E to the Indenture is being furnished herewith.
  ̈ (2) This Note is being transferred to a Non-U.S. Person in compliance with the exemption from registration under the Securities Act of 1933, as amended, provided by Regulation S thereunder, and certification in the form of Exhibit D to the Indenture is being furnished herewith.
or
  ̈ (3) This Note is being transferred other than in accordance with (1) or (2) above and documents are being furnished which comply with the conditions of transfer set forth in this Note and the Indenture.  If none of the foregoing boxes is checked, the Trustee is not obligated to register this Note in the name of any Person other than the Holder hereof unless and until the conditions to any such transfer of registration set forth herein and in the Indenture have been satisfied.
Date:                      Seller
By:        
 
NOTICE: The signature to this assignment must correspond with the name as written upon the face of the within-mentioned instrument in every particular, without alteration or any change whatsoever.
Signature
Guarantee:(1)
(1) Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the Note Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar 

A-8

in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

		
	By:
	     
To be executed by an executive officer

A-9

OPTION OF HOLDER TO ELECT PURCHASE
If you wish to have this Note purchased by the Company pursuant to a Change of Control Offer pursuant to Section 4.07 of the Indenture, check the Box:
  ̈

If you wish to have a portion of this Note purchased by the Company pursuant to a Change of Control Offer pursuant to Section 4.07 of the Indenture, state the amount (in principal amount): 
$     .
Date:        
		
	Your Signature: 
	 
(Sign exactly as your name appears on the other side of this Note)

Signature Guarantee:(2)

(2) Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the Note Transfer agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

A-10

EXHIBIT B
RESTRICTED LEGEND
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND, ACCORDINGLY, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS, EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE.  BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE HOLDER
(1)    REPRESENTS THAT
(A)    IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT)(A “QIB”) OR
(B)    IT IS NOT A U.S. PERSON, IS NOT ACQUIRING THIS NOTE FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON AND IS ACQUIRING THIS NOTE IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT,
(2)    AGREES THAT IT WILL NOT, WITHIN THE TIME PERIOD REFERRED TO UNDER RULE 144 UNDER THE SECURITIES ACT AS IN EFFECT ON THE DATE OF THE TRANSFER OF THIS NOTE, RESELL OR OTHERWISE TRANSFER THIS NOTE EXCEPT
(A)    TO THE COMPANY OR ANY SUBSIDIARY THEREOF,
(B)    TO A PERSON WHOM THE HOLDER REASONABLY BELIEVES IS A QIB PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QIB IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT,
(C)    OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 904 UNDER THE SECURITIES ACT,
(D)    PURSUANT TO THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR
(E)    PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND, IN EACH CASE, IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, AND

B-1

(3)    AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS NOTE OR AN INTEREST HEREIN IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND.  IN CONNECTION WITH ANY TRANSFER OF THIS NOTE OR ANY INTEREST HEREIN WITHIN THE TIME PERIOD REFERRED TO ABOVE, THE HOLDER MUST CHECK THE APPROPRIATE BOX SET FORTH ON THE REVERSE HEREOF RELATING TO THE MANNER OF SUCH TRANSFER AND SUBMIT THIS CERTIFICATE TO THE TRUSTEE.  AS USED HEREIN, THE TERMS “OFFSHORE TRANSACTION,” “UNITED STATES” AND “U.S. PERSON” HAVE THE MEANINGS GIVEN TO THEM BY RULE 902 OF REGULATION S UNDER THE SECURITIES ACT.  THE INDENTURE CONTAINS A PROVISION REQUIRING THE TRUSTEE TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING RESTRICTIONS.

B-2

EXHIBIT C
DTC LEGEND
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN.
TRANSFERS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE.

C-1

EXHIBIT D
Regulation S Certificate
_____________, _____
U.S. Bank National Association  
10 W. Market St., Suite 1150  
Indianapolis, Indiana 46204 
Attn:  Global Corporate Trust Services  
Attention:  Corporate Trust Administration
		
	Re:
	IPALCO Enterprises, Inc. 
3.70% Senior Secured Notes due 2024 (the “Notes”)  
Issued under the Indenture (the “Indenture”) dated as  
of August 22, 2017, relating to the Notes

Dear Sirs:
Terms are used in this Certificate as used in Regulation S (“Regulation S”) under the Securities Act of 1933, as amended (the “Securities Act”), except as otherwise stated herein. 
[CHECK A OR B AS APPLICABLE.]
 
  ̈  A.  This Certificate relates to our proposed transfer of $         principal amount of Notes issued under the Indenture.  We hereby certify as follows:
1.    The offer and sale of the Notes was not and will not be made to a person in the United States (unless such person is excluded from the definition of “U.S. person” pursuant to Rule 902(k)(2)(vi) or the account held by it for which it is acting is excluded from the definition of “U.S. person” pursuant to Rule 902(k)(2)(i) under the circumstances described in Rule 902(g)(3)) and such offer and sale was not and will not be specifically targeted at an identifiable group of U.S. citizens abroad.
2.    Unless the circumstances described in the parenthetical in paragraph 1 above are applicable, either (a) at the time the buy order was originated, the buyer was outside the United States or we and any person acting on our behalf reasonably believed that the buyer was outside the United States or (b) the transaction was executed in, on or through the facilities of a designated offshore securities market, and neither we nor any person acting on our behalf knows that the transaction was pre-arranged with a buyer in the United States.
3.    Neither we, any of our affiliates, nor any person acting on our or their behalf has made any directed selling efforts in the United States with respect to the Notes.

D-1

4.    The proposed transfer of Notes is not part of a plan or scheme to evade the registration requirements of the Securities Act.
5.    If we are a dealer or a person receiving a selling concession, fee or other remuneration in respect of the Notes, and the proposed transfer takes place during the Restricted Period (as defined in the Indenture), or we are an officer or director of the Company or an Initial Purchaser (as defined in the Indenture), we certify that the proposed transfer is being made in accordance with the provisions of Rule 904(b) of Regulation S.
  ̈  B.  This Certificate relates to our proposed exchange of $          principal amount of Notes issued under the Indenture for an equal principal amount of Notes to be held by us.  We hereby certify as follows:
1.    At the time the offer and sale of the Notes was made to us, either (i) we were not in the United States or (ii) we were excluded from the definition of “U.S. person” pursuant to Rule 902(k)(2)(vi) or the account held by us for which we were acting was excluded from the definition of “U.S. person” pursuant to Rule 902(k)(2)(i) under the circumstances described in Rule 902(g)(3); and we were not a member of an identifiable group of U.S. citizens abroad.
2.    Unless the circumstances described in paragraph 1(ii) above are applicable, either (a) at the time our buy order was originated, we were outside the United States or (b) the transaction was executed in, on or through the facilities of a designated offshore securities market and we did not prearrange the transaction in the United States.
3.    The proposed exchange of Notes is not part of a plan or scheme to evade the registration requirements of the Securities Act.
You and the Company are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.
Very truly yours,
[NAME OF SELLER (FOR TRANSFERS) OR OWNER (FOR EXCHANGES)]
		
	By:
	     
Name: 
Title:  
Address:

Date:      

D-2

D-3

EXHIBIT E
Rule 144A Certificate
                          ,        
U.S. Bank National Association  
10 W. Market St., Suite 1150  
Indianapolis, Indiana 46204 
Attn: Global Corporate Trust Services  
Attention:  Corporate Trust Administration
Re:    IPALCO Enterprises, Inc. 
3.70% Senior Secured Notes due 2024 (the “Notes”)  
Issued under the Indenture (the “Indenture”) dated as  
of August 22, 2017, relating to the Notes
Ladies and Gentlemen:
TO BE COMPLETED BY PURCHASER IF (1) ABOVE IS CHECKED.
This Certificate relates to:
[CHECK A OR B AS APPLICABLE.]
  ̈  A.  Our proposed purchase of $             principal amount of Notes issued under the Indenture.
 ̈  B.  Our proposed exchange of $             principal amount of Notes issued under the Indenture for an equal principal amount of Notes to be held by us.
We and, if applicable, each account for which we are acting in the aggregate owned and invested more than $100,000,000 in securities of issuers that are not affiliated with us (or such accounts, if applicable), as of                , 20    , which is a date on or since close of our most recent fiscal year.  We and, if applicable, each account for which we are acting, are a qualified institutional buyer within the meaning of Rule 144A (“Rule 144A”) under the Securities Act of 1933, as amended (the “Securities Act”).  If we are acting on behalf of an account, we exercise sole investment discretion with respect to such account.  We are aware that the transfer of Notes to us, or such exchange, as applicable, is being made in reliance upon the exemption from the provisions of Section 5 of the Securities Act provided by Rule 144A.  Prior to the date of this Certificate we have received such information regarding the Company as we have requested pursuant to Rule 144A(d)(4) or have determined not to request such information.

E-1

You and the Company are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.
Very truly yours,
[NAME OF PURCHASER (FOR TRANSFERS) OR OWNER (FOR EXCHANGES)]
		
	By:
	     
Name: 
Title:  
Address:

Date:      

E-2

EXHIBIT F
[COMPLETE FORM I OR FORM II AS APPLICABLE.] 
[FORM I]
Certificate of Beneficial Ownership
		
	To:
	U.S. Bank National Association  
10 W. Market St., Suite 1150 
Indianapolis, Indiana 46204 
Attn: Global Corporate Trust Services OR

[Euroclear Bank S.A./N.V., as operator of the Euroclear System] OR
[Clearstream Banking S.A.]
		
	Re:
	IPALCO Enterprises, Inc. 
3.70% Senior Secured Notes due 2024 (the “Notes”)  
Issued under the Indenture (the “Indenture”) dated as  
of August 22, 2017, relating to the Notes

Ladies and Gentlemen:
We are the beneficial owner of $          principal amount of Notes issued under the Indenture and represented by a Temporary Offshore Global Note (as defined in the Indenture).
We hereby certify as follows: 
[CHECK A OR B AS APPLICABLE.]
 ̈  A.  We are a non-U.S. person (within the meaning of Regulation S under the Securities Act of 1933, as amended).
 ̈  B.  We are a U.S. person (within the meaning of Regulation S under the Securities Act of 1933, as amended) that purchased the Notes in a transaction that did not require registration under the Securities Act of 1933, as amended.
You and the Company are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

F-1

Very truly yours,
[NAME OF BENEFICIAL OWNER]
		
	By:
	     
Name: 
Title:  
Address:

Date:      

F-2

[FORM II]
Certificate of Beneficial Ownership
		
	To:
	U.S. Bank National Association  
10 W. Market St., Suite 1150 
Indianapolis, Indiana 46204 
Attn:  Global Corporate Trust Services  
Attention:  Corporate Trust Administration

		
	Re:
	IPALCO Enterprises 
3.70% Senior Secured Notes due 2024 (the “Notes”)  
Issued under the Indenture (the “Indenture”) dated as  
of August 22, 2017, relating to the Notes

Ladies and Gentlemen:
This is to certify that based solely on certifications we have received in writing, by tested telex or by electronic transmission from member organizations (“Member Organizations”) appearing in our records as persons being entitled to a portion of the principal amount of Notes represented by a Temporary Offshore Global Note issued under the above-referenced Indenture, that as of the date hereof, $        principal amount of Notes represented by the Temporary Offshore Global Note being submitted herewith for exchange is beneficially owned by persons that are either (i) non-U.S. persons (within the meaning of Regulation S under the Securities Act of 1933, as amended) or (ii) U.S. persons that purchased the Notes in a transaction that did not require registration under the Securities Act of 1933, as amended.
We further certify that (i) we are not submitting herewith for exchange any portion of such Temporary Offshore Global Note excepted in such Member Organization certifications and (ii) as of the date here of we have not received any notification from any Member Organization to the effect that the statements made by such Member Organization with respect to any portion of such Temporary Offshore Global Note submitted herewith for exchange are no longer true and cannot be relied upon as of the date hereof.
You and the Company are entitled to rely upon this Certificate and are irrevocably authorized to produce this Certificate or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.
Yours faithfully,
[EUROCLEAR BANK S.A./N.V., as operator of the Euroclear System]
OR

F-3

[CLEARSTREAM BANKING S.A.]
		
	By:
	     
Name: 
Title:  
Address:

Date:      

F-4

EXHIBIT G
THIS NOTE IS A TEMPORARY GLOBAL NOTE.  PRIOR TO THE EXPIRATION OF THE RESTRICTED PERIOD APPLICABLE HERETO, BENEFICIAL INTERESTS HEREIN MAY NOT BE HELD BY ANY PERSON OTHER THAN (1) A NON-U.S. PERSON OR (2) A U.S. PERSON THAT PURCHASED SUCH INTEREST IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  BENEFICIAL INTERESTS HEREIN ARE NOT EXCHANGEABLE FOR PHYSICAL NOTES OTHER THAN A PERMANENT GLOBAL NOTE IN ACCORDANCE WITH THE TERMS OF THE INDENTURE.  TERMS IN THIS LEGEND ARE USED AS USED IN REGULATION S UNDER THE SECURITIES ACT.

G-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]